10-Q 1 thrm-10q_20180930.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 0-21810

GENTHERM INCORPORATED

(Exact name of registrant as specified in its charter)

| Michigan |  | 95-4318554 |
| (State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.) |
| 21680 Haggerty Road, Northville, MI |  | 48167 |
| (Address of principal executive offices) |  | (Zip Code) |

Registrant’s telephone number, including area code: (248) 504-0500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ |  | Accelerated filer | ☐
Non-accelerated filer | ☐ |  | Smaller reporting company | ☐
Emerging growth company | ☐ |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At October 31, 2018, there were 34,888,527 issued and outstanding shares of Common Stock of the registrant.

GENTHERM INCORPORATED

TABLE OF CONTENTS

Cover
Table of Contents |  |
Part I. Financial Information |  | 3
| Item 1. |  | Financial Statements (Unaudited) |  | 3
|  |  | Consolidated Condensed Balance Sheets |  | 3
|  |  | Consolidated Condensed Statements of Income |  | 4
|  |  | Consolidated Condensed Statements of Comprehensive Income |  | 5
|  |  | Consolidated Condensed Statements of Cash Flows |  | 6
|  |  | Notes to Unaudited Consolidated Condensed Financial Statements |  | 7
| Item 2. |  | Management’s Discussion and Analysis of Financial Condition and Results of Operations |  | 30
| Item 3. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 38
| Item 4. |  | Controls and Procedures |  | 39
Part II. Other Information |  | 40
| Item 1. |  | Legal Proceedings |  | 40
| Item 1A. |  | Risk Factors |  | 40
| Item 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 40
| Item 6. |  | Exhibits |  | 41
Signatures |  | 42

2

PART I. FINANCIAL INFORMATION

ITEM 1. | FINANCIAL STATEMENTS

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

| September 30, 2018 |  |  | December 31, 2017 |
ASSETS |  |  |  |  |  |  |
Current Assets: |  |  |  |  |  |  |
Cash and cash equivalents | $ | 47,152 |  |  | $ | 103,172 |
Accounts receivable, less allowance of $1,114 and $973, respectively |  | 183,476 |  |  |  | 185,058 |
Inventory: |  |  |  |  |  |  |
Raw materials |  | 61,770 |  |  |  | 64,175 |
Work in process |  | 6,671 |  |  |  | 16,139 |
Finished goods |  | 40,148 |  |  |  | 41,095 |
Inventory, net |  | 108,589 |  |  |  | 121,409 |
Derivative financial instruments |  | 1,299 |  |  |  | 213 |
Prepaid expenses and other assets |  | 57,846 |  |  |  | 51,217 |
Assets held for sale |  | 56,184 |  |  |  | — |
Total current assets |  | 454,546 |  |  |  | 461,069 |
Property and equipment, net |  | 189,005 |  |  |  | 200,294 |
Goodwill |  | 55,705 |  |  |  | 69,685 |
Other intangible assets, net |  | 60,202 |  |  |  | 83,286 |
Deferred financing costs |  | 733 |  |  |  | 936 |
Deferred income tax assets |  | 73,221 |  |  |  | 30,152 |
Other non-current assets |  | 11,617 |  |  |  | 37,983 |
Total assets | $ | 845,029 |  |  | $ | 883,405 |
LIABILITIES AND SHAREHOLDERS’ EQUITY |  |  |  |  |  |  |
Current Liabilities: |  |  |  |  |  |  |
Accounts payable | $ | 88,991 |  |  | $ | 89,596 |
Accrued liabilities |  | 72,544 |  |  |  | 77,209 |
Current maturities of long-term debt |  | 3,429 |  |  |  | 3,460 |
Derivative financial instruments |  | — |  |  |  | 1,050 |
Liabilities held for sale |  | 13,473 |  |  |  | — |
Total current liabilities |  | 178,437 |  |  |  | 171,315 |
Pension benefit obligation |  | 7,312 |  |  |  | 7,913 |
Other liabilities |  | 7,488 |  |  |  | 2,747 |
Long-term debt, less current maturities |  | 98,000 |  |  |  | 141,209 |
Deferred income tax liabilities |  | 3,471 |  |  |  | 6,347 |
Total liabilities |  | 294,708 |  |  |  | 329,531 |
Shareholders’ equity: |  |  |  |  |  |  |
Common Stock: |  |  |  |  |  |  |
No par value; 55,000,000 shares authorized, 35,748,829 and 36,761,362 issued and outstanding at September 30, 2018 and December 31, 2017, respectively |  | 218,569 |  |  |  | 265,048 |
Paid-in capital |  | 14,293 |  |  |  | 15,625 |
Accumulated other comprehensive loss |  | (33,877 | ) |  |  | (20,444 | )
Accumulated earnings |  | 351,336 |  |  |  | 293,645 |
Total shareholders’ equity |  | 550,321 |  |  |  | 553,874 |
Total liabilities and shareholders’ equity | $ | 845,029 |  |  | $ | 883,405 |

See accompanying notes to the consolidated condensed financial statements.

3

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Product revenues | $ | 258,939 |  |  | $ | 235,853 |  |  | $ | 784,607 |  |  | $ | 728,498 |
Cost of sales |  | 185,800 |  |  |  | 165,667 |  |  |  | 558,452 |  |  |  | 494,843 |
Gross margin |  | 73,139 |  |  |  | 70,186 |  |  |  | 226,155 |  |  |  | 233,655 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net research and development expenses |  | 19,056 |  |  |  | 19,721 |  |  |  | 63,382 |  |  |  | 60,633 |
Selling, general and administrative expenses |  | 32,552 |  |  |  | 34,331 |  |  |  | 97,920 |  |  |  | 96,912 |
Restructuring expenses |  | 5,818 |  |  |  | — |  |  |  | 12,898 |  |  |  | — |
Total operating expenses |  | 57,426 |  |  |  | 54,052 |  |  |  | 174,200 |  |  |  | 157,545 |
Operating income |  | 15,713 |  |  |  | 16,134 |  |  |  | 51,955 |  |  |  | 76,110 |
Interest expense |  | (1,241 | ) |  |  | (1,250 | ) |  |  | (3,661 | ) |  |  | (3,633 | )
Foreign currency gain (loss) |  | 125 |  |  |  | (7,340 | ) |  |  | 721 |  |  |  | (21,920 | )
Impairment loss |  | (11,476 | ) |  |  | — |  |  |  | (11,476 | ) |  |  | — |
Other income (loss) |  | 212 |  |  |  | (360 | ) |  |  | 1,538 |  |  |  | 145 |
Earnings before income tax |  | 3,333 |  |  |  | 7,184 |  |  |  | 39,077 |  |  |  | 50,702 |
Income tax expense |  | 3,688 |  |  |  | 630 |  |  |  | 9,807 |  |  |  | 10,233 |
Net income (loss) | $ | (355 | ) |  | $ | 6,554 |  |  | $ | 29,270 |  |  | $ | 40,469 |
Basic earnings (loss) per share | $ | (0.01 | ) |  | $ | 0.18 |  |  | $ | 0.80 |  |  | $ | 1.10 |
Diluted earnings (loss) per share | $ | (0.01 | ) |  | $ | 0.18 |  |  | $ | 0.80 |  |  | $ | 1.10 |
Weighted average number of shares – basic |  | 36,104 |  |  |  | 36,742 |  |  |  | 36,364 |  |  |  | 36,713 |
Weighted average number of shares – diluted |  | 36,448 |  |  |  | 36,805 |  |  |  | 36,470 |  |  |  | 36,831 |

See accompanying notes to the consolidated condensed financial statements.

4

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Net income (loss) | $ | (355 | ) |  | $ | 6,554 |  |  | $ | 29,270 |  |  | $ | 40,469 |
Other comprehensive (loss) income, gross of tax: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments (loss) gain |  | (3,266 | ) |  |  | 13,251 |  |  |  | (14,519 | ) |  |  | 42,051 |
Unrealized gain (loss) on foreign currency derivative securities |  | 1,753 |  |  |  | (1,234 | ) |  |  | 2,304 |  |  |  | 2,541 |
Unrealized gain (loss) on commodity derivative securities |  | — |  |  |  | 136 |  |  |  | (218 | ) |  |  | 184 |
Other comprehensive (loss) income, gross of tax | $ | (1,513 | ) |  | $ | 12,153 |  |  | $ | (12,433 | ) |  | $ | 44,776 |
Other comprehensive (loss) income, related tax effect: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cumulative effect of accounting change due to ASU 2018-02 |  | — |  |  |  | — |  |  |  | (40 | ) |  |  | — |
Foreign currency translation adjustments (loss) gain |  | 15 |  |  |  | (49 | ) |  |  | (217 | ) |  |  | (158 | )
Unrealized gain (loss) on foreign currency derivative securities |  | (536 | ) |  |  | 331 |  |  |  | (684 | ) |  |  | (683 | )
Unrealized gain (loss) on commodity derivative securities |  | — |  |  |  | (50 | ) |  |  | (59 | ) |  |  | (67 | )
Other comprehensive (loss) income, related tax effect | $ | (521 | ) |  | $ | 232 |  |  | $ | (1,000 | ) |  | $ | (908 | )
Other comprehensive (loss) income, net of tax | $ | (2,034 | ) |  | $ | 12,385 |  |  | $ | (13,433 | ) |  | $ | 43,868 |
Comprehensive (loss) income | $ | (2,389 | ) |  | $ | 18,939 |  |  | $ | 15,837 |  |  | $ | 84,337 |

See accompanying notes to the consolidated condensed financial statements.

5

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

| Nine Months Ended September 30, |
| 2018 |  |  | 2017 |
Operating Activities: |  |  |  |  |  |  |
Net income | $ | 29,270 |  |  | $ | 40,469 |
Adjustments to reconcile net income to cash provided by operating activities: |  |  |  |  |  |  |
Depreciation and amortization |  | 38,721 |  |  |  | 32,663 |
Deferred income taxes |  | (19 | ) |  |  | (9,059 | )
Stock compensation |  | 6,360 |  |  |  | 8,559 |
Defined benefit plan (income) expense |  | (219 | ) |  |  | 96 |
Provision of doubtful accounts |  | 247 |  |  |  | (353 | )
Loss on sale of property and equipment |  | 2,273 |  |  |  | 868 |
Impairment loss |  | 11,476 |  |  |  | — |
Changes in operating assets and liabilities: |  |  |  |  |  |  |
Accounts receivable |  | (13,855 | ) |  |  | (5,581 | )
Inventory |  | (3,510 | ) |  |  | (4,407 | )
Prepaid expenses and other assets |  | (7,867 | ) |  |  | (555 | )
Accounts payable |  | 8,376 |  |  |  | (7,433 | )
Accrued liabilities |  | (712 | ) |  |  | (39,896 | )
Net cash provided by operating activities |  | 70,541 |  |  |  | 15,371 |
Investing Activities: |  |  |  |  |  |  |
Proceeds from the sale of property and equipment |  | 703 |  |  |  | 41 |
Final payment for acquisition of subsidiary, net of cash acquired |  | (15 | ) |  |  | (2,000 | )
Purchases of property and equipment |  | (31,815 | ) |  |  | (37,181 | )
Net cash used in investing activities |  | (31,127 | ) |  |  | (39,140 | )
Financing Activities: |  |  |  |  |  |  |
Borrowing of debt |  | 18,000 |  |  |  | — |
Repayments of debt |  | (61,210 | ) |  |  | (25,906 | )
Cash paid for the cancellation of restricted stock |  | (882 | ) |  |  | (1,100 | )
Proceeds from the exercise of Common Stock options |  | 14,062 |  |  |  | 2,434 |
Repurchase of Common Stock |  | (64,151 | ) |  |  | (5,326 | )
Net cash used in financing activities |  | (94,181 | ) |  |  | (29,898 | )
Foreign currency effect |  | (1,253 | ) |  |  | 24,106 |
Net decrease in cash and cash equivalents |  | (56,020 | ) |  |  | (29,561 | )
Cash and cash equivalents at beginning of period |  | 103,172 |  |  |  | 177,187 |
Cash and cash equivalents at end of period | $ | 47,152 |  |  | $ | 147,626 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |  |
Cash paid for taxes | $ | 19,255 |  |  | $ | 67,160 |
Cash paid for interest | $ | 3,617 |  |  | $ | 3,171 |
Supplemental disclosure of non-cash transactions: |  |  |  |  |  |  |
Common Stock issued to Board of Directors and employees | $ | 3,893 |  |  | $ | 3,873 |

See accompanying notes to the consolidated condensed financial statements.

6

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 1 – The Company and Subsequent Events

Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Unless the context otherwise requires, the terms “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, environmental product testing and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.

New Strategic Plan

On June 25, 2018, Gentherm announced a new strategic plan intended to improve business performance and position the Company to deliver above-market growth and improved profitability to its shareholders. An important element of the strategy is the Fit-for-Growth initiative that focuses on purchasing excellence, rationalization of research and development activities, reducing selling, general and administrative expense, minimization or elimination of investments in non-core areas and developing a manufacturing footprint commensurate with the new plan. Non-core areas of investment under the Fit-for-Growth initiative are concentrated in the following areas of Gentherm’s industrial segment: California Advanced Research and Development, Gentherm Global Power Technologies (GPT) and Cincinnati Sub Zero’s Industrial Chamber business (CSZ-IC).

The strategy also identified several product categories the Company will exit, including furniture, aviation, battery management electronics, industrial battery packs, automotive thermoelectric generators and other non-core electronics.

Fit-for-Growth

The Fit-for-Growth cost savings initiative began in January 2018. Consultant costs associated with the initiative, some of which were incurred during the first quarter of 2018, were reported in restructuring expenses for both the three and nine-month periods ended September 30, 2018. The total amount of consultant costs incurred during the three- and nine-month periods ended September 30, 2018 was $1,332 and $2,831, respectively. We do not expect to incur additional consultant costs during the fourth quarter of 2018 from implementing Fit-for-Growth.

Gentherm recognized $3,303 and $5,040 in one-time employee termination costs in restructuring expenses pertaining to Fit-for-Growth during the three- and nine-month periods ended September 30, 2018, respectively. We expect to incur an additional $1,220 in one-time employee termination costs during the fourth quarter of 2018. Gentherm recognized $0 and $11 in contract termination costs in restructuring expenses pertaining to Fit-for-Growth during the respective three and nine-month periods ended September 30, 2018. We do not anticipate additional contract termination costs in the future from implementing Fit-for-Growth.

Advanced Research and Development Rationalization and Site Consolidation

In June 2018, Gentherm completed a sale of its battery management systems division located in Irvine, California. A loss on the sale of $1,107 was recognized in restructuring expenses during the nine-month period ended September 30, 2018.

Gentherm completed its site consolidation plan of advanced research and development operations and vacated the two leased facilities in Azusa, California. During the three- and nine-month periods ended September 30,2018, Gentherm recognized $589 and $1,024, respectively, in contract termination costs in restructuring expenses from implementing our site consolidation plan. We do not anticipate incurring additional contract termination costs associated with our advanced research and development rationalization and site consolidation initiative.

7

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 1 – The Company and Subsequent Events – Continued

Gentherm recognized $157 and $1,038 in one-time employee termination costs in restructuring expenses pertaining to the site consolidation plan of advanced research and development operations during the respective three- and nine-month periods ended September 30, 2018. We do not anticipate incurring additional one-time employee termination costs associated with our advanced research and development rationalization and site consolidation initiative.

Lastly, Gentherm recognized $50 and $1,250 in restructuring expenses during the respective three- and nine-month periods ended September 30, 2018 for the disposal of long-lived assets controlled and used in Azusa, California. We do not expect to incur additional asset disposal costs from our exit from Azusa, California.

GPT and CSZ-IC

During the three-month period ended September 30, 2018, Gentherm launched a program to actively market GPT and CSZ-IC to potential buyers and initiated all other actions required to complete the divestiture plan. Gentherm incurred $125 in consultant costs in restructuring expenses to launch the sales plan and does not expect to incur additional consultant costs associated with the plan in the future. Lastly, Gentherm recognized $262 and $472 in one-time employee termination costs in restructuring expenses related to the divestiture process during the respective three- and nine-month periods ended September 30, 2018. We do not anticipate additional one-time employee termination costs in the future from the divestiture of GPT and CSZ-IC. See Note 12 to our consolidated condensed financial statements for additional information regarding the assets and liabilities classified as held for sale.

Restructuring Liability

A reconciliation of the beginning and ending restructuring liability is as follows:

|  | One-Time Employee Termination Benefit Costs |  |  | Contract Termination Costs |  |  | Consulting Costs |  |  |  |  | Asset Disposal Costs |  |  | Total |
Nine Months Ended September 30, 2018 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of period |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ |  | — |  |  | $ | — |
Additions, charged to costs |  |  | 6,550 |  |  |  | 1,035 |  |  |  | 2,956 |  |  |  |  | 2,357 |  |  |  | 12,898 |
Payments |  |  | (5,395 | ) |  |  | (101 | ) |  |  | (2,956 | ) |  |  |  | (2,357 | ) |  |  | (10,809 | )
Balance, end of period |  | $ | 1,155 |  |  | $ | 934 |  |  | $ | — |  |  | $ |  | — |  |  | $ | 2,089 |

The cumulative amount of restructuring expenses incurred and recognized in the automotive reporting segment during the three- and nine-month periods ended September 30, 2018 was $4,332 and $7,578, respectively. The cumulative amount of restructuring expenses incurred and recognized in the industrial reporting segment during the three- and nine-month periods ended September 30, 2018 was $1,486 and $5,320, respectively. See Note 5 to our consolidated condensed financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income.

U.S. Tax Reform

As of December 31, 2017, the Company had not completed its accounting for the tax effects of the Tax Cuts and Jobs Act (Tax Act); however, in accordance with guidance provided by Staff Accounting Bulletin No. 118 (SAB 118), the Company made a provisional estimate of $20,153 for the effects on our existing deferred tax balances, the one-time transition tax and our indefinite reinvestment assertion regarding foreign subsidiary earnings. The measurement period begins in the reporting period that includes the Tax Act’s enactment date, which was December 22, 2017, and ends when the additional information is obtained, prepared, or analyzed to complete the accounting requirements under ASC Topic 740. The measurement periods should not extend beyond one year from the enactment date.

8

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 1 – The Company and Subsequent Events – Continued

As of September 30, 2018, the Company evaluated the provisional amounts initially recorded for the year ended December 31, 2017 and recorded adjustments based on updates to the Company’s assumptions and the application of additional interpretative guidance as issued during 2018. The adjustments are primarily a result of refining the net deferred tax asset position with the completion of our 2017 U.S. income tax return and changing tax accounting methods that affected the timing of certain US tax deductions. These adjustments resulted in (i) a decrease in our existing deferred tax asset balances which resulted in an adjusted provisional income tax expense of $4,950 and (ii) a net increase to the one-time transition tax which resulted in an adjusted provisional income tax expense of $24,625. No adjustment was required to the $9,578 tax benefit included in the provision for income taxes as of December 31, 2017 to offset the one-time transition tax related to the previous deferred tax liability that existed for the undistributed foreign earnings that were not permanently reinvested. As of September 30, 2018, the total adjusted provisional income tax expense was $19,997 for the year ended December 31, 2017.

The Company will continue to evaluate the provisional amounts recorded for the year ended December 31, 2017 throughout the remainder of the measurement period.

Subsequent Events

We have evaluated subsequent events through the date that our consolidated condensed financial statements are issued. No events have taken place that meet the definition of a subsequent event requiring adjustments to or disclosures in this Form 10-Q.

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation

Impairments of Goodwill and Other Intangible Assets

Whenever events or changes in circumstances indicate that it is more likely than not that a reporting unit’s fair value is less than is carrying amount, the Company then compares the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized. The fair value of a reporting unit is estimated by analyzing internal inputs (level 3) to calculate forward values and discounting those values to the present value.

Based on an interim analysis, the Company determined that there were impairment indicators for two of its reporting units and conducted an impairment analysis that concluded $6,151 of goodwill and $3,135 of other intangible assets were impaired and included in impairment losses during the three- and nine-month periods ended September 30, 2018. The Company does not believe that there are impairment indicators of goodwill for any other reporting units, however the Company will continue to assess the impact of significant events or circumstances on its recorded goodwill.

A rolled forward reconciliation of goodwill from December 31, 2017 to September 30, 2018 is as follows:

Nine Months Ended September 30, 2018 |  |  |
Balance, beginning of period | $ | 69,685 |
Goodwill impairment |  | (6,151 | )
Reclassified to Assets held for sale |  | (6,844 | )
Currency impact |  | (985 | )
Balance, end of period | $ | 55,705 |

9

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation – Continued

Assets and Liabilities Held for Sale

The Company classifies assets and liabilities (disposal groups) to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify as a completed sale within one year, except if events or circumstances beyond the Company’s control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.

The Company initially measures a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Gains are not recognized on the sale of a disposal group until the date of sale. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent losses as an adjustment to the carrying value of the disposal group.

The Company reports assets and liabilities of the disposal group in the line items assets held for sale and liabilities held for sale in the Consolidated Condensed Balance Sheet in the period the disposal group meets the criteria to be classified as held for sale. See Note 12 to our consolidated condensed financial statement for information about the assets and liabilities classified as held for sale.

Accounting Principles

Our unaudited consolidated condensed financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the audited annual consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted pursuant to those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring items, considered necessary for a fair presentation of our results of operations, financial position and cash flows have been included. The balance sheet as of December 31, 2017 was derived from audited annual consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Certain reclassifications of prior year’s amounts have been made to conform with the current year’s presentation. Notably, results from asset disposals during the nine-month period ended September 30, 2017 were reclassified from other income to cost of sales. Operating results for the three- and nine-month periods ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018. These consolidated condensed financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2017.

Consolidation

The consolidated financial statements at September 30, 2018 and December 31, 2017 and for the three- and nine-month periods ended September 30, 2018 and 2017, reflect the consolidated financial position, the consolidated operating results and the consolidated cash flows of the Company. Investments in affiliates in which Gentherm would not have control, but would have the ability to exercise significant influence over operating and financial policies, would be accounted for under the equity method. Investments for which Gentherm is not able to exercise significant influence over the investee and which do not have readily determinable fair values are accounted for under the cost method. Intercompany accounts have been eliminated in consolidation.

Use of Estimates

The presentation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ from those estimates and assumptions.

10

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation – Continued

Revenue Recognition

Revenue is recognized from agreements containing enforceable rights and obligations when promised goods are delivered or services are completed, the price is fixed or determinable, and payment has been received or is collectable. The amount of revenue recognized is net of the Company’s obligation for returns, rebates, discounts, taxes, if any, collected from customers, and consideration that is paid to a customer, unless such payment is in exchange for a distinct good or service. The amount of revenue recognized from a contract with a customer reflects the amount of consideration expected to be received in exchange for the transfer of good or services.

Automotive Revenues

The Company sells automotive seat comfort systems, specialized automotive cable systems and automotive thermal convenience products under long-term supply agreements (“LTAs”) and, for arrangements that are less than one year in length, purchase orders. LTAs are multiple-year business awards to provide custom designed parts for a particular automotive vehicle program in quantities and at intervals of the customer’s choosing. LTAs are often multiple-element agreements. The main element in LTAs are production parts; distinct promises from which the customer can benefit separately from other promises or elements in the contract. A second element in LTAs are production part purchase options that provide customers the ability to purchase additional parts at set prices in the future. Judgement is used to determine whether a production part purchase option represents a material right to the customer and should be accounted for as a separate performance obligation. LTAs that provide customers with a purchase option discount incrementally higher than the range discounts typically given to automotive customers contain a material right. The magnitude of change in the year-over-year option prices and the total number of units expected to be ordered are important factors in the calculation of the option’s fair value and the allocation of transaction price.

The price for parts is set at the point in time the customer exercises its option to purchase additional parts from the Company. A firm order, stating the number of each production part to be delivered, is an independent contract with a discrete transaction price. Revenues are allocated to production parts based on the relative standalone selling prices observed on the LTAs. As a practical alternative to estimating the standalone selling price of an option that provides a customer with a material right, the Company allocates transaction price to options by reference to the production part volumes expected to be ordered and the consideration expected to be received. The Company satisfies its obligation to provide product parts to the customer upon shipment.

When an option to purchase additional production parts in the future represents a material right, the customer effectively is paying Gentherm in advance for production parts each time it exercises the option by placing a firm order commitment. Revenue from options containing a material right are recognized on the basis of direct measurement of the value of production parts transferred to date relative to the total number of production parts expected to be delivered over the life of the vehicle program. Judgement is required to determine the pattern and timing with which an option containing a material right is satisfied and the production part is transferred to a customer.

Industrial Revenues

Our industrial business unit generates revenue from the sale of products and services by our wholly-owned subsidiaries Cincinnati Sub-Zero (“CSZ”) and GPT. Industrial business unit revenues and medical business unit revenues discussed below are reported within the Company’s industrial reportable segment (see Note 5). Industrial business unit customers commonly enter into multiple-element agreements for the purchase of products and services. Installation services, for example, are separate and distinct performance obligations that are often included in contracts to purchase customized environmental test chambers. Depending on the application, delivery of an environmental test chamber or remote power generation system to the customer’s place of business can range from two weeks to nine months from commencement of the contract. Installation services, while reliant on the specifications and timing from the customer, rarely remain incomplete more than two months after delivery.

Revenues allocated to environmental test chambers or remote power systems are based on the stand alone selling price of products themselves. Judgement is used to determine the degree to which early pay discounts and other credits are utilized in the calculation of standalone selling price, and only included to the extent it is probable that a significant reversal of any incremental revenue will not occur. Revenues are recognized at the point in time the chamber or power system is shipped to the customer. For contracts that also include a promise for installation, the portion of total transaction price allocated to the installation is recognized as revenue at the point in time the installation is complete.

11

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation – Conti nued

Revenues from our medical business unit are generated from the sale of products and equipment. Our medical products and equipment focus on body and blood temperature management. The Company sells medical products and equipment primarily through distributor and group purchasing organization agreements. These agreements allow member participants to the distributor or group purchasing organization to make purchases at discounted prices negotiated by the distributor or group purchasing organization. A rebate is incurred at the point in time a member participant purchases product covered under these types of agreements. Rebates are accounted for as variable consideration, using an expected value, probability weighted approach, based on the level of sales to the distributor and the time lag between the initial sale and the rebate claim in determining the transaction price of a contract. Revenue is recognized at the point in time the medical products or equipment is transferred to the customer.

Contract Balances

We record a receivable when revenue is recognized at the time of invoicing and unearned revenue when revenue is recognized subsequent to invoicing. For contracts where control of the goods or service is transferred to the customer over time, or whose terms require the customer to make milestone payments throughout the fulfillment period, the timing of revenue recognition is likely to differ from the timing of invoicing to customers.

The opening balance of our accounts receivable, net of allowance for doubtful accounts, was $185,058 as of January 1, 2018.

We record an allowance for doubtful accounts once exposure to collection risk of an account receivable is specifically identified. We analyze the length of time an account receivable is outstanding, as well as a customer’s payment history and ability to pay to determine the need to record an allowance for doubtful accounts.

Activity in the allowance for doubtful accounts was as follows:

Nine Months Ended September 30, 2018 |  |  |
Balance, beginning of period | $ | 973 |
Additions charged to costs |  | 1,063 |
Recoveries recognized in costs |  | (816 | )
Reclassified to Assets held for sale |  | (89 | )
Currency impact |  | (17 | )
Balance, end of period | $ | 1,114 |

Most of Gentherm’s unearned revenue pertains to LTAs containing a material right. In the early periods of an LTA containing a material right, when payments collected from the customer are greater than the standalone selling price of the production parts, revenue associated with the material right is deferred. In future periods, when amounts collected from customers as payment is less than the standalone selling price of the production parts delivered, the deferred revenue is reversed into revenue. For LTAs containing a material right and, thus, the timing of revenue recognition is likely to differ from the timing of invoicing to customer, the aggregate amount of transaction price allocated to material rights that remain unsatisfied as of September 30, 2018 is $1,914. We expect to recognize into revenue, 17% of this balance in the next 3 months, and the remaining 54%, 16%, 8%, 3% and 2% in 2019, 2020, 2021, 2022 and 2023, respectively.

Gentherm often requires milestone payments for contracts to provide environmental test chambers or remote power systems to customers. Milestone payments do not provide the Company with a right to payment for the work completed to date and do not represent the satisfaction of a performance obligation. Milestone payments are deferred and reported within unearned revenue until construction is complete and the unit has been delivered or is installed. If the environmental test chamber contract includes a separate promise to provide installation services, any installation-related payments received from the customer are deferred until the point in time the installation is complete.

12

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation – Continued

The total amount of unearned revenue associated with environmental chamber and remote power system contracts, including environmental chamber contracts that include a separate obligation to provide installation existed as of September 30, 2018 is $4,214. Unearned revenue associated with environmental chamber and remote power system contracts is classified within Liabilities held for sale on the consolidated condensed balance sheet at September 30, 2018 and within Accrued liabilities . See Note 12 to our consolidated condensed financial statement for information about the assets and liabilities classified as held for sale. This entire balance is expected to be recognized into revenue during the next 12 months.

See Note 10 for information regarding the unearned revenue associated with these arrangements, including unearned revenue by segment and amounts recognized into revenue during the most recent nine-month period ending September 30, 2018.

Payment terms for contracts with customers generally range from 30 to 120 days from the date of shipment of goods or completion of service or, if applicable, the scheduled milestone payment due date, and do not include components designed to provide customers with financing.

Assets Recognized from the Costs to Obtain a Contract with a Customer

We recognize an asset for the incremental costs of obtaining a contract with a customer if the benefits of those costs are expected to be realized for a period greater than one year. Total capitalized costs to obtain a contract were immaterial during the periods presented and are included in prepaid expenses and other assets and other non-current assets.

Note 3 – Etratech Acquisition

Etratech designs, develops, manufactures and sells electronic control modules and control systems to customers across a range of industries, including automotive, recreational vehicles and marine, HVAC systems and medical, amongst others. Each function is part of an integrated, customer-focused process designed to exceed customer expectations for product quality, reliability and cost. Etratech’s global manufacturing footprint will enable us to provide customers with scalable and flexible manufacturing solutions across a variety of application and geographies.

Results of operations for Etratech are included in the Company’s consolidated condensed financial statements beginning November 1, 2017. Etratech contributed $12,070 and $42,459 in product revenues and $2,529 and $2,103 in net losses for the three- and nine-month periods ended September 30, 2018, respectively.

Purchase Price Allocation

The purchase price of $65,009, net of cash acquired of $670, has been allocated to the values of assets acquired and liabilities assumed as of November 1, 2017. The purchase price allocation was finalized March 31, 2018. The purchase price allocation as of November 1, 2017 was as follows:

Accounts receivable |  | $ | 12,654 |
Inventory |  |  | 7,014 |
Prepaid expenses and other assets |  |  | 535 |
Property and equipment |  |  | 6,205 |
Customer relationships |  |  | 24,774 |
Technology |  |  | 8,588 |
Goodwill |  |  | 14,881 |
Assumed liabilities |  |  | (9,642 | )
Net assets acquired |  |  | 65,009 |
Cash acquired |  |  | 670 |
Purchase price |  | $ | 65,679 |

The gross contractual amount due of accounts receivable is $12,654, all of which was subsequently collected.

13

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 3 – Etratech Acquisition – Continued

Supplemental Pro Forma Information

The unaudited pro forma combined historical results including the amounts of Etratech revenue and earnings that would have been included in the Company’s consolidated statements of income had the acquisition date been January 1, 2017 is as follows:

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2017 |  |  | 2017 |
Product revenues |  | $ | 250,369 |  |  | $ | 769,845 |
Net income |  | $ | 6,411 |  |  | $ | 41,257 |
Basic earnings per share |  | $ | 0.17 |  |  | $ | 1.12 |
Diluted earnings per share |  | $ | 0.17 |  |  | $ | 1.12 |

The pro forma information includes adjustments for the effect of the amortization of intangible assets recognized in the acquisition. This pro forma information is not indicative of future operating results.

Goodwill

We recorded goodwill of approximately $14,881 arising from the acquisition. The acquired goodwill represents intangible assets that do not qualify for separate recognition. Approximately $8,787 of the goodwill recognized will not be deductible for income tax purposes.

Intangible Assets

In conjunction with the acquisition, intangible assets of $33,362 were recorded. The Company’s estimate of the fair value of these assets at the time of the acquisition was determined with the assistance of an independent third-party valuation firm. As part of the estimated valuation, an estimated useful life for the assets was determined.

Intangible assets, net consisted of the following (balances are lower as of September 30, 2018 than as of November 1, 2017, the acquisition date, due to fluctuations in foreign currency exchange rates totaling $464):

|  | September 30, 2018
|  | Gross Value |  |  | Accumulated Amortization |  |  | Net Value |  |  | Useful Life
Customer relationships |  | $ | 24,424 |  |  | $ | 1,909 |  |  | $ | 22,515 |  |  | 8 -12 yrs
Technology |  |  | 8,474 |  |  |  | 1,501 |  |  |  | 6,973 |  |  | 5 -6 yrs
Total |  | $ | 32,898 |  |  | $ | 3,410 |  |  | $ | 29,488 |  |  |

Amortization expenses of $943 and $2,790 during the three- and nine-month periods ended September 30, 2018, respectively, were recognized in our consolidated condensed statement of income as follows:

|  | Three Months Ended September 30, 2018 |  |  | Nine Months Ended September 30, 2018 |
Product revenues |  | $ | 528 |  |  | $ | 1,562 |
Cost of sales |  |  | 415 |  |  |  | 1,228 |

14

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 3 – Etratech Acquisition – Continued

Amortization expense for the prospective five years is expected to be as follows:

October 1, 2018 through December 31, 2018 |  | $ | 938 |
2019 |  | $ | 3,753 |
2020 |  | $ | 3,753 |
2021 |  | $ | 3,691 |
2022 |  | $ | 3,264 |
2023 |  | $ | 2,590 |

Property, Plant & Equipment

Property and equipment consist of the following:

Asset category |  | Useful life |  | Amount |
Leasehold improvements |  | 10 yrs |  | $ | 342 |
Machinery and equipment |  | 4-11 yrs |  |  | 5,248 |
Furniture and fittings |  | 4 yrs |  |  | 230 |
Motor vehicles |  | 3 yrs |  |  | 25 |
Computer hardware and software |  | 1 yrs |  |  | 360 |
|  |  |  | $ | 6,205 |

Note 4 – Earnings Per Share

Basic earnings per share are computed by dividing net income by the weighted average number of shares of stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential Common Stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents.

The following summarizes the Common Stock included in the basic and diluted shares, as disclosed on the face of the consolidated condensed statements of income:

| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Weighted average number of shares for calculation of basic EPS |  | 36,103,520 |  |  |  | 36,742,168 |  |  |  | 36,364,380 |  |  |  | 36,713,294 |
Stock options, restricted stock awards and restricted stock units under equity incentive plans |  | 344,642 |  |  |  | 62,908 |  |  |  | 105,379 |  |  |  | 117,919 |
Weighted average number of shares for calculation of diluted EPS |  | 36,448,162 |  |  |  | 36,805,076 |  |  |  | 36,469,759 |  |  |  | 36,831,213 |

The following table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.

| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Stock options under equity incentive plans |  | 12,000 |  |  |  | 1,845,784 |  |  |  | 1,359,250 |  |  |  | 1,845,784 |

15

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 5 – Segment Reporting

Segment information is used by management for making strategic operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss. As discussed in Note 3, Gentherm acquired Etratech on November 1, 2017.

The Company’s reportable segments are as follows:

| ● | Automotive – this segment represents the design, development, manufacturing and sales of automotive seat comfort systems, specialized automotive cable systems and certain automotive and non-automotive thermal convenience products. All of our activities with respect to electronics are also included in our Automotive segment because the majority of these activities relate to the manufacture of electronic components for our automotive products or the automotive products of third parties. Etratech’s operating results are included within Gentherm’s Automotive segment due to the concentration of Etratech’s product applications within the automotive, recreational vehicle and marine industries.

| • | Industrial – the combined operating results of GPT, CSZ and Gentherm’s advanced research and development division. During the three-month period ended September 30, 2018, Gentherm launched a program to actively market GPT and CSZ-IC to potential buyers and initiated all other actions required to complete the divestiture plan. See Note 12 to our consolidated condensed financial statements for additional information regarding the Industrial segment assets and liabilities classified as held for sale.

| ● | Reconciling Items – include corporate selling, general and administrative costs and acquisition transaction costs.

The tables below present segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three- and nine-month periods ended September 30, 2018 and 2017. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level. As of September 30, 2018, goodwill assigned to our Automotive and Industrial segments were $37,927 and $30,773, respectively. Due to the classification GPT’s and CSZ-IC’s assets as held for sale, $12,995 of the goodwill assigned to our Industrial segment is classified within Assets held for sale on Gentherm’s consolidated condensed balance sheet as of September 30, 2018. As of September 30, 2017, goodwill assigned to our Automotive and Industrial segments were $23,514 and $30,773, respectively.

Three Months Ended September 30, |  | Automotive |  |  | Industrial |  |  | Reconciling Items |  |  | Consolidated Total |
2018: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Product revenues |  | $ | 236,576 |  |  | $ | 22,363 |  |  | $ |  |  |  | $ | 258,939 |
Depreciation and amortization |  |  | 11,060 |  |  |  | 1,170 |  |  |  | 668 |  |  |  | 12,898 |
Restructuring expenses |  |  | 4,332 |  |  |  | 1,486 |  |  |  | — |  |  |  | 5,818 |
Operating income (loss) |  |  | 38,023 |  |  |  | (4,449 | ) |  |  | (17,861 | ) |  |  | 15,713 |
2017: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Product revenues |  | $ | 215,175 |  |  | $ | 20,678 |  |  | $ | — |  |  | $ | 235,853 |
Depreciation and amortization |  |  | 9,423 |  |  |  | 1,334 |  |  |  | 715 |  |  |  | 11,472 |
Operating income (loss) |  |  | 37,142 |  |  |  | (5,613 | ) |  |  | (15,395 | ) |  |  | 16,134 |

16

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 5 – Segment Reporting – Continued

Nine Months Ended September 30, |  | Automotive |  |  | Industrial |  |  | Reconciling Items |  |  | Consolidated Total |
2018: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Product revenues |  | $ | 717,655 |  |  | $ | 66,952 |  |  | $ | — |  |  | $ | 784,607 |
Depreciation and amortization |  |  | 32,839 |  |  |  | 3,822 |  |  |  | 2,060 |  |  |  | 38,721 |
Restructuring expenses |  |  | 7,578 |  |  |  | 5,320 |  |  |  | — |  |  |  | 12,898 |
Operating income (loss) |  |  | 116,427 |  |  |  | (19,010 | ) |  |  | (45,462 | ) |  |  | 51,955 |
2017: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Product revenues |  | $ | 652,820 |  |  | $ | 75,678 |  |  | $ | — |  |  | $ | 728,498 |
Depreciation and amortization |  |  | 26,602 |  |  |  | 4,040 |  |  |  | 2,021 |  |  |  | 32,663 |
Operating income (loss) |  |  | 127,885 |  |  |  | (10,747 | ) |  |  | (41,028 | ) |  |  | 76,110 |

Total product revenues information by geographic area is as follows:

| Three Months Ended September 30, |
| 2018 |  |  | 2017 |
United States | $ | 125,936 |  |  |  | 49 | % |  | $ | 104,033 |  |  |  | 44 | %
China |  | 22,756 |  |  |  | 9 | % |  |  | 25,741 |  |  |  | 11 | %
Germany |  | 22,681 |  |  |  | 9 | % |  |  | 17,711 |  |  |  | 7 | %
Japan |  | 16,672 |  |  |  | 6 | % |  |  | 15,727 |  |  |  | 7 | %
South Korea |  | 12,814 |  |  |  | 5 | % |  |  | 16,569 |  |  |  | 7 | %
Czech Republic |  | 10,742 |  |  |  | 4 | % |  |  | 9,175 |  |  |  | 4 | %
United Kingdom |  | 9,037 |  |  |  | 3 | % |  |  | 8,143 |  |  |  | 3 | %
Canada |  | 7,778 |  |  |  | 3 | % |  |  | 10,667 |  |  |  | 5 | %
Romania |  | 5,876 |  |  |  | 2 | % |  |  | 5,091 |  |  |  | 2 | %
Other |  | 24,647 |  |  |  | 10 | % |  |  | 22,996 |  |  |  | 10 | %
Total Non-U.S. |  | 133,003 |  |  |  | 51 | % |  |  | 131,820 |  |  |  | 56 | %
| $ | 258,939 |  |  |  | 100 | % |  | $ | 235,853 |  |  |  | 100 | %

| Nine Months Ended September 30, |
| 2018 |  |  | 2017 |
United States | $ | 369,798 |  |  |  | 47 | % |  | $ | 337,697 |  |  |  | 46 | %
China |  | 71,887 |  |  |  | 9 | % |  |  | 66,168 |  |  |  | 9 | %
Germany |  | 68,670 |  |  |  | 9 | % |  |  | 53,273 |  |  |  | 7 | %
Japan |  | 43,520 |  |  |  | 6 | % |  |  | 43,103 |  |  |  | 6 | %
South Korea |  | 42,419 |  |  |  | 5 | % |  |  | 50,714 |  |  |  | 7 | %
Czech Republic |  | 33,563 |  |  |  | 4 | % |  |  | 29,826 |  |  |  | 4 | %
Canada |  | 33,482 |  |  |  | 4 | % |  |  | 32,709 |  |  |  | 5 | %
United Kingdom |  | 28,349 |  |  |  | 4 | % |  |  | 26,250 |  |  |  | 4 | %
Romania |  | 16,775 |  |  |  | 2 | % |  |  | 13,173 |  |  |  | 2 | %
Other |  | 76,144 |  |  |  | 10 | % |  |  | 75,585 |  |  |  | 10 | %
Total Non-U.S. |  | 414,809 |  |  |  | 53 | % |  |  | 390,801 |  |  |  | 54 | %
| $ | 784,607 |  |  |  | 100 | % |  | $ | 728,498 |  |  |  | 100 | %

17

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 6 – Debt

Amended Credit Agreement

The Company, together with certain direct and indirect subsidiaries, have an outstanding credit agreement (as amended, the “Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent. The Credit Agreement provides the Company a revolving credit note (“U.S. Revolving Note”) with a maximum borrowing capacity of $350,000.

All subsidiary borrowers and guarantors participating in the Credit Agreement have entered into a related pledge and security agreement. The security agreement grants a security interest to the lenders in substantially all of the personal property of subsidiaries designated as borrowers to secure their respective obligations under the Credit Agreement, including the stock and membership interests of specified subsidiaries (limited to 66% of the stock in the case of certain non-U.S. subsidiaries). The Credit Agreement restricts the amount of dividend payments the Company can make to shareholders.

The Credit Agreement requires the Company to maintain a minimum Consolidated Interest Coverage Ratio and Consolidated Leverage Ratio. Definitions for these financial ratios are provided in the Credit Agreement.

Under the Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The rate for Base Rate Loans is equal to the highest of the Federal Funds Rate (2.18% at September 30, 2018) plus 0.50%, Bank of America’s prime rate (5.25% at September 30, 2018), or a one-month Eurocurrency rate (0.00% at September 30, 2018) plus 1.00%. The rate for Eurocurrency Rate Loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (2.26% at September 30, 2018). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly.

The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.00%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.00%, respectively, for Base Rate Loans.

The Company also has two fixed interest rate loans with the German Investment Corporation (“DEG”), a subsidiary of KfW Banking Group, a Germany government-owned development bank:

DEG China Loan

The first DEG loan, a loan we used to fund capital investments in China (the “DEG China Loan”), is subject to semi-annual principal payments that began March, 2015 and will end September, 2019. Under the terms of the DEG China Loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio, as defined by the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Ltd.

DEG Vietnam Loan

The Company’s second fixed interest rate loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”). The DEG Vietnam Loan is subject to semi-annual principal payments that began November, 2017 and will end May, 2023. Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Current Ratio, Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.

Undrawn borrowing capacity under the U.S. Revolving Note was $260,758 as of September 30, 2018. The following table summarizes the Company’s debt at September 30, 2018 and at December 31, 2017.

18

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 6 – Deb t – Continued

| September 30, 2018 |  |  | December 31, 2017 |
| Interest Rate |  |  | Principal Balance |  |  | Principal Balance |
Credit Agreement: |  |  |  |  |  |  |  |  |  |  |
Revolving Note (U.S. Dollar Denominations) |  | 3.74 | % |  | $ | 88,000 |  |  | $ | 129,000 |
DEG China Loan |  | 4.25 | % |  |  | 929 |  |  |  | 1,919 |
DEG Vietnam Loan |  | 5.21 | % |  |  | 12,500 |  |  |  | 13,750 |
Total debt |  |  |  |  |  | 101,429 |  |  |  | 144,669 |
Current portion |  |  |  |  |  | (3,429 | ) |  |  | (3,460 | )
Long-term debt, less current maturities |  |  |  |  | $ | 98,000 |  |  | $ | 141,209 |

The scheduled principal maturities of our debt as of September 30, 2018 are as follows:

Year |  | Revolving Note (U.S. Dollar) |  |  | DEG China Note |  |  | DEG Vietnam Note |  |  | Total |
Remainder of 2018 |  | $ | — |  |  | $ | — |  |  | $ | 1,250 |  |  | $ | 1,250 |
2019 |  |  | — |  |  |  | 929 |  |  |  | 2,500 |  |  |  | 3,429 |
2020 |  |  | — |  |  |  | — |  |  |  | 2,500 |  |  |  | 2,500 |
2021 |  |  | 88,000 |  |  |  | — |  |  |  | 2,500 |  |  |  | 90,500 |
2022 |  |  | — |  |  |  | — |  |  |  | 2,500 |  |  |  | 2,500 |
2023 |  |  | — |  |  |  | — |  |  |  | 1,250 |  |  |  | 1,250 |
Total |  | $ | 88,000 |  |  | $ | 929 |  |  | $ | 12,500 |  |  | $ | 101,429 |

Principal outstanding under the U.S. Revolving Note will be due and payable in full on March 17, 2021. As of September 30, 2018, we were in compliance, in all material respects, with all terms as outlined in the Credit Agreement, DEG China Loan and DEG Vietnam Loan.

Note 7 – Derivative Financial Instruments

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in the location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $38,537 and $29,273 outstanding as of September 30, 2018 and December 31, 2017, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. We had copper commodity swap contracts with a notional value of $0 and $404 outstanding at September 30, 2018 and December 31, 2017, respectively.

19

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 7 – Derivative Financial Instruments – Continued

We do not enter into derivative financial instrument arrangements for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income (loss) in the consolidated condensed balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income (loss) is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. See Note 9 for unrealized gains (losses) associated with derivatives reported in accumulated other comprehensive income as of December 31, 2017 that was reclassified into earnings during 2018. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of September 30, 2018 is as follows:

|  |  |  |  |  | Asset Derivatives |  |  | Liability Derivatives |  |  | Net Asset/ (Liabilities) |
|  | Hedge Designation |  | Fair Value Hierarchy |  | Balance Sheet Location |  |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |  |
Foreign currency derivatives |  | Cash flow hedge |  | Level 2 |  |  | Current assets |  |  | $ | 1,299 |  |  | Current liabilities |  | $ | — |  |  | $ | 1,299 |

Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:

|  | Location |  | Three Months Ended September 30, 2018 |  |  | Three Months Ended September 30, 2017 |  |  | Nine Months Ended September 30, 2018 |  |  | Nine Months Ended September 30, 2017 |
Foreign currency derivatives |  | Product revenues |  | $ | — |  |  | $ | 54 |  |  | $ | — |  |  | $ | 54 |
|  | Cost of sales |  |  | 391 |  |  |  | 1,424 |  |  |  | (214 | ) |  |  | 1,303 |
|  | Selling, general and administrative |  | — |  |  | — |  |  |  | 75 |  |  |  | (216 | )
|  | Other comprehensive income |  |  | 1,753 |  |  | (1,234 | ) |  |  | 2,304 |  |  |  | 2,541 |
|  | Foreign currency (loss) gain |  |  | 11 |  |  | 15 |  |  |  | 58 |  |  |  | (62 | )
Total foreign currency derivatives |  |  |  | $ | 2,155 |  |  | $ | 259 |  |  | $ | 2,223 |  |  | $ | 3,620 |
Commodity derivatives |  | Cost of sales |  | $ | — |  |  | $ | (4 | ) |  |  | 145 |  |  | $ | 25 |
|  | Other comprehensive income |  | — |  |  | 136 |  |  |  | (218 | ) |  |  | 184 |
Total commodity derivatives |  |  |  | $ | — |  |  | $ | 132 |  |  | $$ | (73 | ) |  | $ | 209 |

We did not incur any hedge ineffectiveness during the three- and nine-month periods ended September 30, 2018 and 2017.

Note 8 – Fair Value Measurement

The Company bases fair value on a price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.

20

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 8 – Fair Value Measurement – Continued

Level 3: Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

Except for derivative instruments (see Note 7), pension liabilities, pension plan assets, a corporate owned life insurance policy and assets held for sale, the Company had no material financial assets and liabilities that are carried at fair value at September 30, 2018 and December 31, 2017. The carrying amounts of financial instruments comprising cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to the relatively short maturity of such instruments. The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs).

As of September 30, 2018, and December 31, 2017, the carrying values of the Credit Agreement indebtedness were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 6). Discount rates used to measure the fair value of the DEG Vietnam Loan and DEG China Loan are based on quoted swap rates. As of September 30, 2018, the carrying values of the DEG Vietnam Loan and DEG China Loan were $12,500 and $929, respectively, as compared to an estimated fair value of $12,400 and $900, respectively. As of December 31, 2017, the carrying value of the DEG Vietnam Loan and DEG China Loan were $13,750 and $1,919, respectively, as compared to an estimated fair value of $13,600 and $2,000, respectively.

Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable. As of September 30, 2018 and December 31, 2017, the Company did not realize any changes to the fair value of these assets due to the non-occurrence of events or circumstances that could negatively impact their recoverability.

Note 9 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the three and nine-month periods ended September 30, 2018 and September 30, 2017 are as follows:

|  | Defined Benefit Pension Plans |  |  | Foreign Currency Translation Adjustments |  |  | Foreign Currency Hedge Derivatives |  |  | Total |
Balance at June 30, 2018 |  | $ | (2,406 | ) |  | $ | (29,040 | ) |  | $ | (397 | ) |  | $ | (31,843 | )
Other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | (3,266 | ) |  |  | 1,586 |  |  |  | (1,680 | )
Income tax effect of other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | 15 |  |  |  | (491 | ) |  |  | (476 | )
Amounts reclassified from accumulated other comprehensive (income) loss into net income |  |  | — |  |  |  | — |  |  |  | 167 | a |  |  | 167 |
Income taxes reclassified into net income |  |  | — |  |  |  | — |  |  |  | (45 | ) |  |  | (45 | )
Net current period other comprehensive income (loss) |  |  | — |  |  |  | (3,251 | ) |  |  | 1,217 |  |  |  | (2,034 | )
Balance at September 30, 2018 |  | $ | (2,406 | ) |  | $ | (32,291 | ) |  | $ | 820 |  |  | $ | (33,877 | )

(a) | The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

21

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 9 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss) – Continued

|  | Defined Benefit Pension Plans |  |  | Foreign Currency Translation Adjustments |  |  | Commodity Hedge Derivatives |  |  | Foreign Currency Hedge Derivatives |  |  | Total |
Balance at June 30, 2017 |  | $ | (2,550 | ) |  | $ | (37,071 | ) |  | $ | 272 |  |  | $ | 1,741 |  |  | $ | (37,608 | )
Other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | 13,251 |  |  |  | 153 |  |  |  | 106 |  |  |  | 13,510 |
Income tax effect of other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | (49 | ) |  |  | (56 | ) |  |  | (29 | ) |  |  | (134 | )
Amounts reclassified from accumulated other comprehensive (income) loss into net income |  |  | — |  |  |  | — |  |  |  | (17 | ) | a |  | (1,340 | ) | a |  | (1,357 | )
Income taxes reclassified into net income |  |  | — |  |  |  | — |  |  |  | 6 |  |  |  | 360 |  |  |  | 366 |
Net current period other comprehensive income (loss) |  |  | — |  |  |  | 13,202 |  |  |  | 86 |  |  |  | (903 | ) |  |  | 12,385 |
Balance at September 30, 2017 |  | $ | (2,550 | ) |  | $ | (23,869 | ) |  | $ | 358 |  |  | $ | 838 |  |  | $ | (25,223 | )

(a)The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

|  | Defined Benefit Pension Plans |  |  | Foreign Currency Translation Adjustments |  |  | Commodity Hedge Derivatives |  |  | Foreign Currency Hedge Derivatives |  |  | Total |
Balance at December 31, 2017 |  | $ | (2,366 | ) |  | $ | (17,555 | ) |  | $ | 277 |  |  | $ | (800 | ) |  | $ | (20,444 | )
Cumulative effect of accounting change due to adoption of ASU 2018-02 |  |  | (40 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (40 | )
Other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | (14,519 | ) |  |  | — |  |  |  | 2,048 |  |  |  | (12,471 | )
Income tax effect of other comprehensive income (loss) before reclassifications |  |  | — |  |  |  | (217 | ) |  |  | — |  |  |  | (615 | ) |  |  | (832 | )
Amounts reclassified from accumulated other comprehensive (income) loss into net income |  |  | — |  |  |  | — |  |  |  | (218 | ) | a |  | 256 | a |  |  | 38 |
Income taxes reclassified into net income |  |  | — |  |  |  | — |  |  |  | (59 | ) |  |  | (69 | ) |  |  | (128 | )
Net current period other comprehensive income (loss) |  |  | (40 | ) |  |  | (14,736 | ) |  |  | (277 | ) |  |  | 1,620 |  |  |  | (13,433 | )
Balance at September 30, 2018 |  | $ | (2,406 | ) |  | $ | (32,291 | ) |  | $ | — |  |  | $ | 820 |  |  | $ | (33,877 | )

(a) | The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

22

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 9 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss) – Continued

|  | Defined Benefit Pension Plans |  |  | Foreign Currency Translation Adjustments |  |  | Commodity Hedge Derivatives |  |  | Foreign Currency Hedge Derivatives |  |  | Total |
Balance at December 31, 2016 |  | $ | (2,550 | ) |  | $ | (65,762 | ) |  | $ | 241 |  |  | $ | (1,020 | ) |  | $ | (69,091 | )
Other comprehensive income before reclassifications |  |  | — |  |  |  | 42,051 |  |  |  | 231 |  |  |  | 3,071 |  |  |  | 45,353 |
Income tax effect of other comprehensive income before reclassifications |  |  | — |  |  |  | (158 | ) |  |  | (84 | ) |  |  | (825 | ) |  |  | (1,067 | )
Amounts reclassified from accumulated other comprehensive (income) loss into net income |  |  | — |  |  |  | — |  |  |  | (47 | ) | a |  | (530 | ) | a |  | (577 | )
Income taxes reclassified into net income |  |  | — |  |  |  | — |  |  |  | 17 |  |  |  | 142 |  |  |  | 159 |
Net current period other comprehensive income |  |  | — |  |  |  | 41,893 |  |  |  | 117 |  |  |  | 1,858 |  |  |  | 43,868 |
Balance at September 30, 2017 |  | $ | (2,550 | ) |  | $ | (23,869 | ) |  | $ | 358 |  |  | $ | 838 |  |  | $ | (25,223 | )

(a) | The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

We expect all of the existing gains and losses related to foreign currency derivatives and commodity derivatives reported in accumulated other comprehensive income (loss) as of September 30, 2018 to be reclassified into earnings during the next twelve months. See Note 7 for additional information about derivative financial instruments and the effects from reclassification to net income.

Note 10 – Unearned Revenue

Unearned revenue by segment was as follows:

| September 30, 2018 |  |  | December 31, 2017 |
Automotive | $ | 1,914 |  |  | $ | — |
Industrial |  | 4,214 |  |  |  | 4,889 |
Total | $ | 6,128 |  |  | $ | 4,889 |

Changes in unearned revenue were as follows:

Nine Months Ended September 30, 2018 |  |  |
Balance, beginning of period | $ | 4,889 |
Additions to unearned revenue |  | 15,467 |
Reclassified to revenue |  | (14,193 | )
Currency impacts |  | (35 | )
Balance, end of period | $ | 6,128 |

Revenue allocated to remaining performance obligations represent contracted revenue that has not yet been recognized, which includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods.

23

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 11 – New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Revenue from Contracts with Customers

In May 2014, the FASB issued Accounting Standard Update (“ASU”) 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principal is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those good or services. Issuers are to use a five-step contract review model to ensure revenue is measured, recognized, and disclosed in accordance with this principle. The FASB issued several amendments to the update, including a one-year deferral of the original effective date, and new methods for identifying performance obligations that are intended to reduce the cost and complexity of compliance.

We adopted ASU 2014-09 and related amendments effective January 1, 2018 using the cumulative catch-up transition method, which required us to disclose the cumulative effect of initially applying the update recognized at the date of initial application. We elected to apply the guidance in ASU 2014-09 to contracts that were not completed at January 1, 2018.

The most significant impact from adoption of ASU 2014-09 occurred within our Automotive segment and relates to our accounting for production part purchase options that grant customers a material right to purchase additional parts under long-term supply agreements in the future. Due to the complexity of certain of our automotive supply contracts, the actual revenue recognition treatment for customer purchase options will depend on contract-specific terms and could vary from other contracts that are similar in nature. Revenue recognition related to goods and services reported in the Industrial segment remains substantially unchanged.

The amount by which each financial statement line item was affected by application of ASU 2014-09 and related amendments during the three- and nine-month periods ended September 30, 2018 is as follows:

|  | Revenue Based on Previously Effective Guidance |  |  | New Revenue Standard Adjustment |  |  | Revenue Based on New Revenue Standard |
Three Months Ended September 30, 2018 |  |  |  |  |  |  |  |  |  |  |  |
Product revenues |  | $ | 258,184 |  |  | $ | 755 |  |  | $ | 258,939 |
Income tax expense (benefit) |  |  | 3,842 |  |  |  | (154 | ) |  |  | 3,688 |
Net income (loss) |  |  | (956 | ) |  |  | 601 |  |  |  | (355 | )
Basic earnings (loss) per share |  |  | (0.03 | ) |  |  | 0.02 |  |  |  | (0.01 | )
Diluted earnings (loss) per share |  |  | (0.03 | ) |  |  | 0.02 |  |  |  | (0.01 | )
Nine Months Ended September 30, 2018 |  |  |  |  |  |  |  |  |  |  |  |
Product revenues |  | $ | 782,451 |  |  | $ | 2,156 |  |  | $ | 784,607 |
Income tax expense (benefit) |  |  | 10,247 |  |  |  | (440 | ) |  |  | 9,807 |
Net income |  |  | 27,554 |  |  |  | 1,716 |  |  |  | 29,270 |
Basic earnings per share |  |  | 0.76 |  |  |  | 0.04 |  |  |  | 0.80 |
Diluted earnings per share |  |  | 0.76 |  |  |  | 0.04 |  |  |  | 0.80 |

24

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 11 – New Accounting Pronouncements – Continued

|  | Revenue Based on Previously Effective Guidance |  |  | New Revenue Standard Adjustment |  |  | Revenue Based on New Revenue Standard |
Balance Sheet September 30, 2018 |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, net of allowance for doubtful accounts |  | $ | 183,476 |  |  | $ | — |  |  | $ | 183,476 |
Accrued liabilities |  | $ | 70,630 |  |  | $ | 1,914 |  |  | $ | 72,544 |
Unearned revenue |  | $ | 4,214 |  |  | $ | 1,914 |  |  | $ | 6,128 |
Deferred income taxes, net |  | $ | 69,360 |  |  | $ | 390 |  |  | $ | 69,750 |
Accumulated earnings |  | $ | 352,860 |  |  | $ | (1,524 | ) |  | $ | 351,336 |

Adoption of ASU 2014-09 and related amendments had no impact to cash from or used in operating, investing or financing activities on our consolidated condensed statements of cash flows.

Statement of Cash Flows

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.” ASU 2016-15 provides guidance on the classification of eight specific cash receipt and cash payment transactions in the statement of cash flows. The Company focused its evaluation on the following transactions to determine the effect ASU 2016-15 will have on the Company’s Consolidated Statements of Cash Flows:

| 1) | Debt extinguishment payments and debt prepayments are to be shown as cash outflows for financing activities. Previously, Gentherm classified debt extinguishment payments within operating activities.

| 2) | Payments made to settle contingent consideration liabilities not made soon after the acquisition date of a business combination should be recognized as cash outflows for financing activities up to the amount of the liability recognized at the acquisition date. Payments, or the portion of a payment, to settle contingent consideration liabilities that exceed the amount of the liability recognized at the acquisition date will be recognized as cash outflows for operating activities.

| 3) | Cash receipts from the settlement of insurance claims, excluding those related to corporate-owned life insurance policies shall be classified on the basis of the related insurance coverage. For example, proceeds received to cover claims issued under product recall liability insurance would be classified as cash inflows from operating activities.

| 4) | Cash receipts from the settlement of corporate-owned life insurance policies shall be classified as cash inflows from investing activities.

We have adopted ASU 2016-15 and related amendments effective January 1, 2018. None of the cash receipt and cash payment transactions addressed by the update occurred during any of the periods presented in this report. Adoption of this update and related amendments did not have a material impact on the cash flows of the Company.

Income Taxes

In October 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” ASU 2016-16 modifies the current prohibition to recognize deferred income taxes from differences between the tax basis of assets in the buyer’s tax jurisdiction and their cost resulting from an intra-entity transfer from one tax-paying component to another tax-paying component of the same consolidated group. Under current GAAP, deferred income taxes for intra-entity asset transfers are not recognized until the asset is sold to an outside party. ASU 2016-16 allows entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs.

25

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 11 – New Accounting Pronouncements – Continued

We adopted ASU 2016-16 and related amendments effective January 1, 2018 on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of such adoption date. As a result of the amendments in ASU 2016-16, a favorable adjustment of $31,645 was recorded directly to retained earnings during the nine-month period ending September 30, 2018. The new deferred tax assets will be recognized ratably over the useful life of the applicable assets.

Accumulated Other Comprehensive Income

In February 2018, the FASB issued ASU 2018-02, “Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” ASU 2018-02 provides a remedy to a narrow-scope financial reporting issue created by the Tax Act. The Tax Act required entities to adjust deferred tax assets and liabilities to reflect the impact from newly enacted lower corporate income tax rates, and recognize the effect in income from continuing operations. This requirement applied to all deferred tax assets and liabilities, even those which arose from transactions originally recognized in other comprehensive income. The amendments in ASU 2018-02 allow adjustments to deferred tax assets and liabilities due to newly enacted lower corporate income tax rates to be recognized in retained earnings, if those deferred tax balances arose from transactions originally recognized in other comprehensive income.

Income tax effects are released from accumulated other comprehensive income and recorded against the deferred tax balance in the consolidated balance sheet when the underlying activity is realized.

ASU 2018-02 is effective for annual and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update is permitted, including adoption in any interim period for which financial statements have not yet been issued. The amendments in ASU 2018-02 must be applied in the period of adoption or retrospectively to each period in which the effect of the change in U.S. federal corporate income tax rate in the Tax Act is recognized. We elected to early adopt ASU 2018-02 and related amendments effective January 1, 2018. An adjustment of $40 was recognized against retained earnings for effect of the change in the federal corporate income tax rate on deferred tax amounts. There are no related adjustments to the Company’s valuation allowance and no other income tax effects from the Tax Act on balances that remain in accumulated other comprehensive income were reclassified.

Tax Act

In January 2018, the FASB released guidance on the accounting for tax on the global intangible low-taxed income (“GILTI”) provisions of the Tax Act. The GILTI provisions impose a tax on foreign income in excess of deemed return on tangible assets of foreign corporations. During the first quarter of 2018, the Company elected to treat any potential GILTI inclusions as a period cost.

Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 modified the concept of impairment of goodwill to be a condition that exists when the carrying value of a reporting unit that includes goodwill exceeds its fair value. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill allocated to that reporting unit. Entities no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination.

ASU 2017-04 is effective for annual and any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-04 must be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company has adopted the accounting principles in ASU 2017-04 and applied them to our test for goodwill impairment. See Note 12 for information about the goodwill impairment loss recognized during the three- and nine-month periods ended September 30, 2018.

26

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 11 – New Accounting Pronouncements – Continued

Recently Issued Accounting Pronouncements Not Yet Adopted

Cloud Computing Arrangements That Are Service Contracts

In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 provides guidance on when costs incurred to implement a hosting arrangement that is a service contract are and are not capitalized, aligning with the guidance for capitalizing implementation costs incurred to develop or obtain internal-use software. Entities must first determine the project stage of the implementation activity; depending on their nature, costs for implementation activities in the application development stage are capitalized and costs incurred during the preliminary project and post-implementation stages are expensed as the activities are performed. Capitalized implementation costs should be amortized over the term of the hosting arrangement on a straight-line basis and presented in the same line items in the consolidated condensed statement of income as the expense for fees for the associated hosting arrangements. Similarly, capitalized implementation costs should be presented in same line item in the balance sheet as prepaid fees for the associated hosting arrangement and cash flows from capitalized implementation costs should be classified in the same manner as cash flows for the fees for the associated hosting arrangement.

ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of the amendments in this update is permitted, including adoption in any interim period for which financial statements have not yet been issued. ASU 2018-15 permits two methods of adoption: prospectively to costs for activities performed on or after the date the entity first applies the content from the update, or retrospectively to all periods presented. We are currently in the process of determining the impact implementation of ASU 2018-15 will have on the Company’s financial statement note disclosures.

Retirement Benefits

In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” The amendments in ASU 2018-14 were developed using the concepts incorporated in the FASB’s Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018. The amendments in this update remove the following disclosure requirements, among others, from Subtopic 715-20:

| 1) | The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year.

| 2) | The amount and timing of plan assets expected to be returned to the employer.

The following disclosure requirements were added to Subtopic 715-20:

| 1) | The weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates.

| 2) | An explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period.

ASU 2018-14 is effective for annual periods ending after December 15, 2020. Early adoption of the amendments in this update are permitted. Entities should apply the amendments in this update on a retrospective basis to all periods presented. We are currently in the process of determining the impact implementation of ASU 2018-14 will have on the Company’s financial statement note disclosures.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” The amendments in ASU 2018-13 were developed using the concepts incorporated in the FASBs Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018. The amendments in this update remove the following disclosure requirements from Topic 820:

| 1) | The amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy.

| 2) | The policy for timing of transfer between levels.

27

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 11 – New Accounting Pronouncements – Continued

| 3) | The valuation processes for Level 3 fair value measurements.

The following disclosure requirements were added to Topic 820:

| 1) | The changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period.

| 2) | The range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements.

ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of disclosures that are removed is permitted, but adoption is delayed for the new additional disclosures until their effective date. The amendments in ASU 2018-13 that provide for new additional disclosure should be applied on a prospective basis, while all other amendments should be applied retrospectively to all periods presented upon their effective date. We are currently in the process of determining the impact implementation of ASU 2018-13 will have on the Company’s financial statement note disclosures.

Leases

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 requires lessees to recognize on their balance sheet a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Payments to be made in optional periods should be included in the measurement of lease assets and liabilities if the lessee is reasonably certain it will exercise an option to extend the lease or not exercise an option to terminate the lease. While ASU 2016-02 continues to differentiate between finance or capital leases and operating leases, the principal change from current lease accounting guidance is that lease assets and liabilities arising from operating leases will be recognized on the balance sheet.

ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted. The FASB has issued several amendments to ASU 2016-02, including ASU 2018-11, “Leases (Topic 842): Targeted Improvements” that introduced an additional transition method permitting an entity to initially apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption.

ASU 2016-02 includes optional practical expedients intended to reduce the cost and complexity to implement the new lease standard, such as an option to maintain the current lease classification for all existing lease arrangements and the option to use hindsight in evaluating lessee options to extend or terminate a lease. We expect to elect these practical expedients. The Company expects to add right-of-use assets and the corresponding liabilities to the consolidated condensed balance sheet less that 5% of total assets as of the implementation date, depending on the ultimate selection of appropriate discount rates for cash flow under the leases.

Note 12 – Assets and Liabilities Held for Sale

As of September 30, 2018, Gentherm determined GPT and CSZ-IC met the held for sale criteria and recorded an impairment on assets as held for sale of $2,190 in impairment loss to adjust net book value to fair value less costs to sell. See Note 2 for information about the Company’s held for sale accounting policy, including a description of the criteria necessary for a disposal group to qualify for classification as held for sale. GPT and CSZ-IC did not meet the criteria to be classified as a discontinued operation.

28

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 12 – Assets and Liabilities Held for Sale – Continued

The assets and liabilities of the disposal group classified as held for sale as of September 30, 2018 are as follows:

Accounts receivable, less allowance of $89 | $ | 11,562 |
Inventory, net |  | 14,435 |
Prepaid expenses and other assets |  | 533 |
Property and equipment, net |  | 13,259 |
Goodwill |  | 6,844 |
Other intangible assets, net |  | 6,552 |
Deferred income tax assets |  | 4,798 |
Other non-current assets |  | 391 |
Impairment loss |  | (2,190 | )
Total assets held for sale | $ | 56,184 |
Accounts payable | $ | 3,124 |
Accrued liabilities |  | 10,349 |
Total liabilities held for sale | $ | 13,473 |

Losses before income taxes from GPT and CSZ-IC during the three- and nine-month periods ended September 30, 2018, including $2,190 in impairment loss recognized on held for sale assets, $6,151 in impairment loss on goodwill and $3,135 in impairment loss recognized on other intangible assets, was $12,894 and $15,378, respectively. Losses before income taxes from GPT and CSZ-IC during the three- and nine-month periods ended September 30, 2017, was $2,660 and $1,551, respectively. Management’s estimates used to record impairment expense are inherently uncertain and may change in future periods.

29

ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as our ability to execute our new strategic plan, our ability to finance sufficient working capital, the amount of availability under our credit agreement and other indebtedness, our ability to continue to maintain or increase sales and profits of our operations, and the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs. Reference is made in particular to forward-looking statements included in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 1 to the consolidated condensed financial statements. Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof or as of the date specified and are based on management’s current expectations and beliefs. Such statements are subject to a number of assumptions, risks, uncertainties and other factors, which are set forth in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2017, and subsequent reports filed with or furnished to the Securities and Exchange Commission, and which could cause actual results to differ materially from that described in the forward-looking statements. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2017.

Overview

Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, environmental product testing and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.

Our automotive products are sold to automobile and light truck OEMs or their tier one suppliers. Inherent to the automotive supplier market are costs and commitments that are incurred well in advance of the receipt of orders and resulting revenues from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle.

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial. See Note 5 to our consolidated condensed financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income. The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

Etratech

On November 1, 2017, we acquired substantially all of the assets and assumed substantially all of the operating liabilities of Etratech Inc. (“Etratech”), an Ontario corporation and all of the outstanding shares of Etratech Hong Kong, an entity organized under the laws of Hong Kong, in an all-cash transaction. Etratech manufactures advanced electronic controls and control systems for the automotive, RV and marine, security, medical and other industries. Etratech’s world headquarters and North American manufacturing operations are located in Burlington, Canada. See Note 3 to the consolidated condensed financial statements for additional information regarding the acquisition of Etratech.

30

New Strategic Plan

On June 25, 2018, Gentherm announced a new strategic plan intended to improve business performance and position the company to deliver above-market growth and improved profitability to its shareholders. An important element of the strategy is the Fit-for-Growth initiative that focuses on purchasing excellence, rationalization of research and development activities and expenses, reducing selling, general and administrative expense, minimization or elimination of investments in non-core areas and developing a manufacturing footprint commensurate with the new plan. Non-core areas of investment under the Fit-for-Growth initiative are concentrated in the following areas of Gentherm’s industrial segment: California Advanced Research and Development, Gentherm Global Power Technologies (“GPT”) and Cincinnati Sub Zero’s Industrial Chamber business (“CSZ-IC”).

The strategy also identified several product categories the Company will exit, including furniture, aviation, battery management electronics, industrial battery packs, automotive thermoelectric generators and other non-core electronics.

See Note 1 to our consolidated condensed financial statements for information about our Fit-for-Growth initiative, related cost savings and related restructuring costs.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. See Note 2 to our consolidated condensed financial statements for information about our critical accounting policies. See Note 11 for information about accounting standard updates adopted during the nine-month period ended September 30, 2018 and their impact on the Company’s consolidated financial statements, and recently issued accounting policies not yet adopted.

Results of Operations Third Quarter 2018 Compared with Third Quarter 2017

Product Revenues. Product revenues for the three-month period ended September 30, 2018 (“Third Quarter 2018”) were $258.9 million compared with product revenues of $235.9 million for the three-month period ended September 30, 2017 (“Third Quarter 2017”), an increase of $23.1 million, or 9.8%. The increase included higher product revenues in the automotive segment, which increased by $21.4 million, or 9.9%, to $236.6 million, and higher industrial segment product revenues which increased by $1.7 million, or 8.1%, to $22.4 million. The higher automotive segment sales included $12.0 million related to the acquisition of Etratech. Etratech was acquired on November 1, 2017 and therefore no product revenues were reported for Etratech during Third Quarter 2017. Foreign currency translation decreased product revenues by $1.1 million.

Our automotive segment revenues continue to outperform automotive vehicle production volumes. Automotive production in North America, our most important geographic market, was 2.0% higher during Third Quarter 2018 as compared to Third Quarter 2017, however, this was significantly offset by decreases of 5.1%, 4.8% and 3.7% in Europe, Japan and Korea, and the Greater China regions, respectively. On a combined basis and weighted for the Company’s revenue in each region, automotive vehicle production declined by 1.2% in these key markets. These lower production rates, particularly for automotive production in Europe, were partially attributable to the negative impact of the new Worldwide Harmonized Light Vehicle Test Procedure (“WLTP”) regulations in Europe.

Adjusting for the currency translation impact and for the Etratech acquisition, automotive segment product revenue increased by 3.5% led by a return to growth in climate control seat (“CCS”) revenues and higher battery thermal management (“BTM”) revenues. CCS revenues increased by $4.2 million, or 4.5%, to $97.9 million due to new product launches and the stronger North America production volumes. BTM revenues increased $4.7 million, or 171%, to $7.5 million due to the current year launches of the actively cooled version on the Mercedes S-Class and the Jeep Wrangler. Other products with revenue growth included steering wheel heaters, which revenues increased by $1.7 million, or 10.1% to $18.1 million, and automotive cable systems, which revenues grew by $1.3 million, or 5.6%, to $25.0 million. These amounts were partially offset by lower revenues from seat heaters, which revenues decreased by $7.0 million, or 9.0%, to $70.8 million and, on a pro-forma basis, lower revenues from Etratech, which revenues totaled $12.0 million during Third Quarter 2018. Seat heater revenue was disproportionately impacted by the lower automotive production in Europe and Asia and by the small unfavorable currency translation impact. Etratech’s Third Quarter 2018 revenues were $2.5 million, or 17.1%, lower than Etratech’s pro forma Third Quarter 2017 revenue of $14.5 million, which is not included in the Company’s Third Quarter 2017 revenue since Etratech was acquired on November 1, 2017. This decrease in pro forma revenue was due to lower shipments of electronic modules to the softening recreational vehicle market, a discontinuation of a vehicle platform by an automotive OEM customer for which Etratech is a supplier of electronic modules, and decreased volume on another vehicle platform using the same electronic module that is planned to end during 2019. Both vehicles are from the sedan segment that has recently experienced weak growth in North America. Without Etratech product revenues, the automotive segment organic growth was 4.9%.

31

Higher revenues in the industrial segment were attributable to higher revenue of Cincinnati Sub-Zero (“CSZ”) medical products, which revenues increased by $2.4 million, or 40.0%, to $8.3 million partially offset by decreases in revenues of Gentherm Global Power Technologies (“GPT”) and the CSZ industri al chamber business of $212 thousand, or 4.7% and $470 thousand, or 4.6%, respectively. During the 2018 second quarter, the Company announced that both the GPT and CSZ industrial test equipment businesses would be sold. Both were reclassified during Thir d Quarter 2018 as assets held for sale (see Note 12). Higher medical product revenue was driven by improved market penetration resulting from the implementation of a direct sales force during 2017. Product revenues from GPT, which totaled $4.3 million, d ecreased mainly due to significantly lower custom project revenue. Custom projects, which typically represent more than 50% of GPT’s product revenue, tend to vary significantly period-to-period due to timing of the relatively large per unit revenue. Lower CSZ industrial te s t equipment revenues were mainly due to lower product revenue on custom climate testing chambers which were unusually high during Third Quarter 2017 as a result of the shipment of several large custom projects.

Cost of Sales. Cost of sales increased to $185.8 million during Third Quarter 2018 from $165.6 million during Third Quarter 2017. This increase of $20.2 million, or 12.2%, was due to the higher product revenue and a lower gross margin percentage. The gross margin percentage during Third Quarter 2018 decreased to 28.2% from 29.8% during Third Quarter 2017 primarily due to the lower margin of Etratech, lower margin of BTM associated with the launch phase of the new actively cooled technology programs, and the initial impact of tariffs which became effective during the quarter. These were partially offset by improved product mix and fixed cost leverage from higher unit volume in aggregate. Etratech’s product revenues, which were not included in the Company’s Third Quarter 2017 product revenues, have a lower gross margin percentage in the ordinary course as compared to other products. The new actively cooled battery thermal management product being launched in two of the Company’s manufacturing facilities is anticipated to generate annual revenue in the range of $50 to $60 million, but it is still in an early phase with only $4.6 million in product revenues during the Third Quarter 2018. Lower gross margin on this product during this period is due to launch related expenses and higher fixed overhead costs, including depreciation expense, being incurred in anticipation for the expected future volumes. We expect that higher revenues of BTM units will more than offset these expenses in future periods. The favorable shift in product mix largely was due to higher sales for higher margin products including CCS.

On July 6, 2018, tariffs announced by the Office of the United States Trade Representative (USTR) under the Section 301 Action went into effect. All items identified as classified under the Harmonized Tariff Schedule of the United States (HTSUS) with a country of origin of China are subject to a 25% duty upon importation into the United States. Gentherm purchases raw material components, including products manufactured in our China facilities, which are subject to the tariff. As a result, we incurred approximately $500 thousand in higher raw material expenses during the Third Quarter 2018 and estimate an increase ranging from $3 to $5 million on an annualized basis starting in the 2018 fourth quarter. This estimate includes the 25% duty affecting identified items under HTSUS, plus an additional 25% duty on a second statement of goods that has been proposed but has not gone into effect. We are working with our suppliers and customers to mitigate the impact from these tariffs to the Company’s operating results.

Net Research and Development Expenses. Net research and development expenses were $19.1 million during Third Quarter 2018 compared to $19.7 million in Third Quarter 2017, a decrease of $665 thousand, or 3.4%. Net research and development expenses continue to steadily decrease during 2018 and were down by 18.3% from the 2018 first quarter and down 9.4% from the 2018 second quarter. These sequential decreases are the direct result of the Company’s focused portfolio and Fit-for-Growth cost reduction initiatives. The lower expenses for the Third Quarter 2018 was partially offset by an increase of $1.5 million associated with both the acquisition related research and development costs of Etratech and higher costs for product development activities related to new products for the medical business and for development of an advanced integrated heating, ventilation, and air conditioning (“HVAC”) solution for the automotive market called Climate Sense.

Research and development reimbursement totaled $5.5 million during Third Quarter 2018 compared $4.0 million during Third Quarter 2017. This increase was mainly attributable to development expense reimbursements paid by customers for products launched during the period and the addition of Etratech.

Selling, General and Administrative Expenses. Selling, general and administrative expenses were $32.6 million during Third Quarter 2018, a decrease of $1.8 million from $34.3 million during Third Quarter 2017. The Third Quarter 2018 amount included a higher mark-to-market adjustment on cash-settled stock options totaling $3.2 million and selling, general and administrative expenses associated with the acquisition of Etratech totaling $1.3 million. The Third Quarter 2017 amount included CEO transition expenses of $3.8 million. Adjusting for these impacts, selling, general and administrative expenses decreased by $2.6 million or 8.4%. This decrease is associated with the cost reduction activities of the Company’s new strategic initiatives and the Fit-for-Growth program. On a sequential basis, selling, general and administrative expenses decreased 3.2% from the 2018 second quarter and 11.7% from the 2018 first quarter after adjusting for the higher mark-to-market adjustment on cash-settled stock options.

Restructuring expenses. During Third Quarter 2018, the Company recognized $5.8 million in restructuring charges which resulted from completed actions associated with its Fit-for-Growth program as more fully described above. The completed actions to

32

date under Fit-for-Growth are expected to deliver annualized savings of approximately $30.0 mill ion. This amount, along with additional identified savings that are in the planning stage, is expected to reduce annual costs by $65.0 million. Our overall savings target continues to be $75.0 million. No restructuring charges were incurred in Third Quar ter 2017.

Impairment loss. During the Third Quarter 2018, the Company recorded an impairment loss totaling $11.5 million associated with the Company’s plans to divest GPT and the CSZ industrial chamber business, both of which are included in the industrial segment. The loss is not expected to be deductible for income tax purposes.

Foreign currency gain (loss). During Third Quarter 2018 we incurred a net foreign currency gain of $125 thousand which included a net realized gain of $1.1 million and a net unrealized loss of $1.0 million. The unrealized loss was primarily the result of holding significant amounts of U.S. Dollar (“USD”) cash at our subsidiaries in Europe which have the European Euro (“EUR”) as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During Third Quarter 2017, we had a foreign currency loss of $7.3 million which included an unrealized loss of $6.0 million. In comparison to Third Quarter 2017, the foreign currency impact in Third Quarter 2018 was lower due to a smaller change in currency exchange rates during Third Quarter 2018 as compared to Third Quarter 2017.

Income Tax Expense. We recorded an income tax expense of $3.7 million during Third Quarter 2018 on earnings before income tax of $3.3 million. The pre-tax earnings amount included the non-deductible impairment loss of $11.5 million. Adjusting for the impairment loss, the effective tax rate was 25% for the Third Quarter 2018. During Third Quarter 2017, we recorded an income tax expense of $630 thousand on earnings before tax of $7.2 million, or 9%. The effective tax rate for Third Quarter 2018 differed from the Federal statutory rate of 21% primarily due to increased international provisions from the U.S. tax reform, such as global intangible low-tax income (“GILTI”), enacted in December 2017, partly offset by favorable excess tax benefits on stock option exercises and certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions. The effective tax rate for Third Quarter 2017 was lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

Industrial Segment Operating Loss. The Industrial segment, which includes CSZ, GPT and our advanced research and development activities, reported an operating loss totaling $4.4 million and $5.6 million during Third Quarter 2018 and Third Quarter 2017, respectively. We incurred these losses for several reasons. First, the advanced research and development activities, the total cost for which were $3.0 million and $3.1 million, during Third Quarter 2018 and Third Quarter 2017, respectively, are focused on products and technologies that are currently not generating product revenues. Second, in conjunction with the Fit-for-Growth program, some of these advanced research and development activities have been curtailed or ceased and a process has been started to consolidate our advanced research facilities into fewer locations. These changes are expected to lead to lower spending rates in future periods. We expect that the remaining advanced technology projects will generate profitable revenue in future periods. In addition, CSZ’s $1.2 million of expenses associated with a new direct sales force is not yet fully offset by a corresponding increase in the amount of revenue and related operating income. We continue to believe that the direct sales force will lead to higher CSZ product revenue in future periods that will generate operating profits in excess of the costs for the direct sales team.

Results of Operations Year to Date 2018 Compared with Year to Date 2017

Product Revenues. Product revenues for the nine-month period ended September 30, 2018 (“YTD 2018”) were $784.6 million compared with product revenues of $728.5 million for the nine-month period ended September 30, 2017 (“YTD 2017”), an increase of $56.1 million, or 7.7%. The increase included higher product revenues in the automotive segment, which increased by $64.8 million, or 9.9%, to $717.6 million, partially offset by lower industrial segment product revenues which decreased by $8.7 million, or 11.5%, to $67.0 million. The higher automotive segment sales included $42.4 million related to the acquisition of Etratech. Etratech was acquired on November 1, 2017 and therefore no product revenues were reported for Etratech during YTD 2017. Foreign currency translation increased product revenues by $16.0 million.

Our automotive segment revenues outperformed automotive vehicle production volumes during YTD 2018. Automotive production in North America, our most important market, was 1.3% lower during YTD 2018 as compared to YTD 2017. This production decrease along with lower production levels in the Japan and Korea market of 3.0% was offset slightly by higher production levels in the Greater China region and Europe of 1.4% and 0.2%, respectively. On a combined basis and weighted for the Company’s revenue in each region, automotive vehicle production declined by 0.7% in these markets. These lower rates were partially attributable to the negative impact of the new Worldwide Harmonized Light Vehicle Test Procedure (“WLTP”) regulations in Europe.

Adjusting for the currency translation impact and for the Etratech acquisition, automotive segment product revenue increased by 1.1% due to higher revenue for all automotive products except Climate Control Seats (“CCS”). Battery Thermal Management (“BTM”) revenues contributed the largest increase totaling $11.7 million, or 163%, due to the current year launches of the actively

33

cooled version on the Mercedes S-Class and the Jeep Wrangler. Other products showing significant growth included automotive cables which increased by $10.1 million, or 15.1%, to $77.5 million, s teering w heel h eaters which increased by $7.2 million, or 15.7% to $53.2 million and a utomotive seat heaters which grew by $5.9 million, or 2.6%, to $235.2 million. These amounts were partially offset by lower revenues for CCS which decreased by $17.8 million, or 6.0%, to $276.8 million. Lower CCS revenue was attributable to unfavorable mix between the higher priced active cooling technology and the lower priced heated and ventilated version.

Lower revenues in the industrial segment were attributable to decreased revenue of Gentherm Global Power Technologies (“GPT”) and the CSZ industrial chamber business of $5.4 million, or 27.8%, and $3.2 million, or 9.6%, respectively. During the 2018 second quarter, the Company announced that both the GPT and CSZ industrial test equipment businesses would be sold. Both were reclassified during Third Quarter 2018 as assets held for sale.

Cost of Sales. Cost of sales increased to $558.5 million during YTD 2018 from $494.8 million during YTD 2017. This increase of $63.6 million, or 12.9%, was due to the higher product revenue and a lower gross margin percentage. The gross margin percentage during YTD 2018 decreased to 28.8% from 32.1% during YTD 2017 mainly as a result of timing differences between annual customer price decreases compared to supplier cost reductions, the lower margin of Etratech, changes in product mix favoring lower margin products, lower margin on BTM associated with the launch phase of the new actively cooled technology programs and the initial impact of tariffs which became effective during Third Quarter 2018. These unfavorable effects were partially offset by fixed cost leverage from higher unit volume. Annual price reductions start in the first quarter and are expected to be offset by lower supplier and other costs as those programs begin to take effect throughout the year. Etratech’s product revenues, which were not included in the Company’s YTD 2017 product revenues, have a lower normal gross margin percentage as compared to other products. An unfavorable shift in product mix largely was due to lower sales for higher margin products including CCS and GPT. The new actively cooled BTM product being launched in two of the Company’s manufacturing facilities is anticipated to generate annual revenue in the range of $50 to $60 million but is still in the early phase with only $10.5 million in product revenues during YTD 2018. Lower gross margin on this product during this period is due to launch related expenses and higher fixed overhead costs, including depreciation expense, being incurred in anticipation for the much higher expected volumes. We expect that higher revenues of BTM units will offset these expenses in future periods.

Net Research and Development Expenses. Net research and development expenses were $63.4 million during YTD 2018 compared to $60.6 million in YTD 2017, an increase of $2.7 million, or 4.5%. This increase was primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. The increase also included approximately $1.4 million in foreign currency translation and the net research and development expenses of Etratech totaling $1.3 million. These amounts were partially offset by $4.7 million in higher research and development reimbursements.

Research and development reimbursement totaled $12.5 million during YTD 2018 and $7.8 million during YTD 2017. This increase was mainly attributable to development expense reimbursements paid by customers for products launched during the period and the addition of Etratech.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $97.9 million during YTD 2018, an increase of $1.0 million, or 1.0%, from $96.9 million during YTD 2017. This increase includes approximately $1.1 million in higher expenses related to currency translation and $4.5 million in selling, general and administrative expenses of Etratech. These increases were partially offset by lower expenses associated with the cost reduction activities of the Company’s new strategic initiatives.

Foreign currency gain (loss). During YTD 2018, we incurred a net foreign currency gain of $721 thousand which included a net realized gain of $1.1 million and a net unrealized loss of $1.0 million. The unrealized gain is primarily the result of holding significant amounts of USD cash at our subsidiaries in Europe which have EUR as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During YTD 2018, the USD strengthened relative to the EUR. If the USD begins to weaken we will likely have unrealized currency losses whereas if the USD continues to strengthen we will likely have additional unrealized gains. In YTD 2017, we had a net foreign currency loss of $21.9 million. In comparison to YTD 2017, the foreign currency impact in YTD 2018 was lower due to a smaller change in currency exchange rates during YTD 2018 as compared to YTD 2017.

Income Tax Expense. We recorded an income tax expense of $9.8 million during YTD 2018 on earnings before income tax of $39.1 million. The pre-tax earnings amount included the non-deductible impairment loss of $11.5 million. Adjusting for the impairment loss, the effective tax rate was 19.4% for YTD 2018. During YTD 2017, we recorded an income tax expense of $10.2 million on earnings before tax of $50.7 million, or 20%. The effective tax rate for YTD 2018 differed from the Federal statutory rate of 21% primarily due to the impact of discrete adjustments, including a favorable excess tax benefit on stock option exercises, certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions and the impact of lower statutory rates for

34

our subsidiaries operating in foreign jurisdictions offset by the int ernational provisions from the U.S. tax reform, such as GILTI, enacted in December 2017. The effective tax rate for YTD 2017 was lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

Industrial Segment Operating Loss. The Industrial segment, which includes CSZ, GPT and our advanced research and development activities, reported an operating loss totaling $19.0 million and $10.7 million during YTD 2018 and YTD 2017, respectively. We incurred these losses for several reasons. First, the advanced research and development activities, the total cost for which were $9.9 million and $10.3 million, during YTD 2018 and YTD 2017, respectively, are focused on products and technologies that are currently not generating product revenues. Second, in conjunction with the Fit-for-Growth initiative, some of these activities have been curtailed or ceased and a process has been started to consolidate our advanced research facilities into few locations. These changes are expected to lead to lower spending rates in future periods. Because of this, the industrial segment operating loss included a portion of the restructuring charge totaling $5.3 million. We expect that the remaining advanced technology projects will generate profitable revenue in future periods. Next, CSZ’s $3.6 million of expenses associated with a new direct sales force is not yet fully offset by a corresponding increase in the amount of revenue and related operating income. We continue to believe that the direct sales force will lead to higher CSZ product revenue in future periods that will generate operating profits in excess of the costs for the direct sales team.

Liquidity and Capital Resources

Cash and Cash Flows

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Our new strategic plan sets forth a capital allocation strategy that includes a targeted debt-to-earnings leverage ratio and allows for some of our cash flow to be paid back to investors through Common Stock repurchases. On June 25, 2018, our Board of Directors increased the Company’s stock repurchase authorization to $300 million, of which $227 million of availability remained as of September 30, 2018. This authorization expires on December 31, 2020. Based on its current operating plan, management believes cash and cash equivalents at September 30, 2018, together with cash flows from operating activities, and borrowing available under our credit agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisition or several smaller acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future operations and business strategy.

The following table represents our cash and cash equivalents and short-term investments:

|  | Nine Months Ended September 30, 2018 |  |  | Year Ended December 31, 2017 |
|  | (In thousands) |
Cash and cash equivalents at beginning of period |  | $ | 103,172 |  |  | $ | 177,187 |
Cash provided by operating activities |  |  | 70,541 |  |  |  | 49,880 |
Cash used in investing activities |  |  | (31,127 | ) |  |  | (117,688 | )
Cash used in financing activities |  |  | (94,181 | ) |  |  | (31,564 | )
Foreign currency effect on cash and cash equivalents |  |  | (1,253 | ) |  |  | 25,357 |
Cash and cash equivalents at end of period |  | $ | 47,152 |  |  | $ | 103,172 |

Cash Flows From Operating Activities

We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows from operating activities during YTD 2018 and YTD 2017:

35

|  | Nine Months Ended September 30, |
|  | 2018 |  |  | 2017 |  |  | Change |
Operating Activities: |  | (In thousands) |
Net income |  | $ | 29,270 |  |  | $ | 40,469 |  |  | $ | (11,199 | )
Non-cash adjustments to reconcile net income to cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 38,721 |  |  |  | 32,663 |  |  |  | 6,058 |
Deferred income taxes |  |  | (19 | ) |  |  | (9,059 | ) |  |  | 9,040 |
Stock compensation |  |  | 6,360 |  |  |  | 8,559 |  |  |  | (2,199 | )
Defined benefit plan expense |  |  | (219 | ) |  |  | 96 |  |  |  | (315 | )
Provision for doubtful accounts |  |  | 247 |  |  |  | (353 | ) |  |  | 600 |
Impairment loss |  |  | 11,476 |  |  |  | — |  |  |  | 11,476 |
Loss on sale of property and equipment |  |  | 2,273 |  |  |  | 868 |  |  |  | 1,405 |
Net income before changes in operating assets and liabilities |  |  | 88,109 |  |  |  | 73,243 |  |  |  | 14,866 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable |  |  | (13,855 | ) |  |  | (5,581 | ) |  |  | (8,274 | )
Inventory |  |  | (3,510 | ) |  |  | (4,407 | ) |  |  | 897 |
Prepaid expenses and other assets |  |  | (7,867 | ) |  |  | (555 | ) |  |  | (7,312 | )
Accounts payable |  |  | 8,376 |  |  |  | (7,433 | ) |  |  | 15,809 |
Accrued liabilities |  |  | (712 | ) |  |  | (39,896 | ) |  |  | 39,184 |
Net cash provided by operating activities |  |  | 70,541 |  |  |  | 15,371 |  |  |  | 55,170 |

Cash provided by operating activities during YTD 2018 was $70.5 million, representing an increase of $55.2 million from cash provided in operating activities during YTD 2017, which was $15.4 million. The following table highlights significant differences between the operating cash flows for the periods ending September 30, 2018 and 2017, respectively:

(In thousands)
Net cash provided by operating activities during YTD 2017 | $ | 15,371 |
Increase from higher net income before changes in operating assets and liabilities |  | 14,866 |
Taxes paid related to the Reorganization (as defined below) |  | 35,100 |
Other changes in working capital, net. |  | 5,204 |
Net cash provided by operating activities during YTD 2018 | $ | 70,541 |

Net cash provided by operating activities before changes in operating assets and liabilities increased during YTD 2018 due to higher revenues partially offset by higher cash based operating expenses.

In addition, operating cash flows were lower due to income tax payments related to reorganization transactions of our North American business operations (the “Reorganization”). As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations were consolidated into our existing European and North American facilities.

Related to these reorganization transactions, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7.6 million during 2016. Additionally, the Company incurred income tax expense of $2.5 million related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.

In addition to the $7.6 million of withholding tax and $2.5 million of income taxes, the Company was required to make a one-time income tax payment of approximately $32.6 million. The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2.5 million and $32.6 million were paid during the first quarter of 2017.

Other changes in working capital, net primarily consist of favorable cash flows related to accounts receivable, inventory, prepaid expenses and other assets and unfavorable amounts related to accounts payable.

36

Working Capital

The following table illustrates changes in working capital during YTD 2018:

(In thousands)
Working capital at December 31, 2017 | $ | 289,754 |
Loan repayments |  | (61,210 | )
U.S. Revolving Note borrowings |  | 18,000 |
Stock repurchases |  | (64,151 | )
Proceeds from the exercise of Common Stock options |  | 14,062 |
Foreign currency effect on working capital |  | (1,253 | )
Increase in accounts receivable |  | 13,855 |
Increase in tax receivables |  | 8,169 |
Increase in inventory |  | 3,510 |
Increase in prepaid expenses and other assets |  | 7,867 |
Non-current assets classified as held for sale |  | 29,654 |
Adoption of ASU 2016-16 |  | 22,585 |
Adoption of ASU 2014-09 |  | (4,105 | )
Other Items |  | (628 | )
Working capital at September 30, 2018 | $ | 276,109 |

Our working capital decreased due to a net repayment of a portion of the Company’s outstanding debt balance and cash paid for the repurchase of Common Stock, partially offset by several significant increases, including additional U.S. Revolving Note borrowings, increases to current assets, the classification of non-current assets as held for sale, and non-cash adjustments from the adoption of new accounting standard updates. Working capital was also impacted by an increase in account receivable and inventory, which was driven by higher sales in September 2018 as compared to December 2017. Our sales are typically lower in December each year due to temporary factory holiday shut-downs at our automotive customers. Gentherm recognized an increase to current tax receivables related to timing of required payments to tax authorities. During YTD 2018, Gentherm determined that GPT and CSZ-IC (disposal group) met the held for sale criteria and classified all assets and liabilities as held for sale within current assets and current liabilities, respectively. See Note 12 to our consolidated condensed financial statement for information about the assets and liabilities classified as held for sale. Lastly, working capital was impacted by the adoption of Accounting Standard Update 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory” and Accounting Standard Update 2014-09, “Revenue from Contracts with Customers (Topic 606).” See Note 2 to our consolidated condensed financial statements for information about these accounting standard updates and their impact on the Company’s consolidated condensed financial statements.

Cash Flows From Investing Activities

Cash used in investing activities was $31.1 million during YTD 2018, reflecting purchases of property and equipment related to the expansion of production capacity, including at our newest facilities in Mexico, Vietnam, Macedonia and our Etratech facility in Canada.

Cash Flows From Financing Activities

Cash used in financing activities was $94.2 million during YTD 2018, reflecting payments of principal on the U.S. Revolving Note, the DEG China Loan and the DEG Vietnam Loan totaling $61.2 million in aggregate. As of September 30, 2018, the total availability under the U.S. Revolving Note was $260.8 million. Cash was also paid for cancellations of restricted stock awards totaling $882 thousand, and for the repurchase of Common Stock totaling $64.2 million.

Off-Balance Sheet Arrangements

We use letters of credit to guarantee our performance under specific construction contracts executed by our subsidiaries, GPT and CSZ. The expiration dates of the letter of credit contracts coincide with the expected completion date of the contract. Extensions are normally made if performance obligations continue beyond the expected completion date. At September 30, 2018, we had outstanding letters of credit of $1.2 million, an increase from $141 thousand at December 31, 2017.

37

ITEM 3. | QUANTITATIVE AND QUALITATI VE DISCLOSURES ABOUT MARKET RISK

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $38.6 million and $29.3 million outstanding at September 30, 2018 and December 31, 2017, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. We had copper commodity swap contracts with a notional value of $0 and $404 thousand outstanding at September 30, 2018 and December 31, 2017, respectively.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income (loss) in the consolidated condensed balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income (loss) is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of September 30, 2018 is set forth in Note 7 to the consolidated condensed financial statements included herein.

Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD) or European Euros (€EUR), as indicated in parentheses.

September 30, 2018

|  | Expected Maturity Date |
|  | 2018 |  |  | 2019 |  |  | 2020 |  |  | 2021 |  |  | 2022 |  |  | Thereafter |  |  | Total |  |  | Fair Value |
|  | (In thousands except rate information) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long Term Debt: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fixed Rate (€EUR) |  | $ | — |  |  | $ | 929 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  | $ | 929 |  |  | $ | 900 |
Fixed Interest Rate |  |  |  |  |  |  | 4.25 | % |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.25 | % |  |  |  |
Variable Rate ($USD) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  | $ | 88,000 |  |  |  | — |  |  | $ | 88,000 |  |  | $ | 88,000 |
Average Interest Rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.74 | % |  |  |  |  |  |  | 3.74 | % |  |  |  |
Fixed Rate ($USD) |  | $ | 1,250 |  |  | $ | 2,500 |  |  | $ | 2,500 |  |  | $ | 2,500 |  |  | $ | 2,500 |  |  | $ | 1,250 |  |  | $ | 12,500 |  |  | $ | 12,400 |
Fixed Interest Rate |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  | 5.21 | % |  |  |  |

38

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

September 30, 2018

|  | Expected Maturity or Transaction Date |
Anticipated Transactions And Related Derivatives |  | 2018 |  |  | 2019 |  |  | 2020 |  |  | 2021 |  |  | 2022 |  |  | Thereafter |  |  | Total |  |  | Fair Value |
|  | (In thousands except rate information) |
$U.S. functional currency |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Forward Exchange Agreements: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(Receive MXN/Pay USD$) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total Contract Amount |  | $ | 13,026 |  |  | $ | 25,547 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  | $ | 38,573 |  |  | $ | 1,299 |
Average Contract Rate |  |  | 19.58 |  |  |  | 19.96 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 19.83 |  |  |  |  |

ITEM 4. | CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2018, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2018 that have materially affected, or are reasonably likely to materially effect, our internal control over financial reporting.

39

P ART II OTHER INFORMATION

ITEM 1. | LEGAL PROCEEDINGS

We are subject to litigation from time to time in the ordinary course of business, however there is no current material pending litigation to which we are a party and no material legal proceeding was terminated, settled or otherwise resolved during the three- or nine-month periods ended September 30, 2018.

ITEM 1A. | RISK FACTORS

International tariffs, including tariffs applied to goods traded between the United States and China, could materially and adversely affect our business and results of operations.

During 2018, the U.S. and China have applied significant tariffs to certain of each other’s exports. The institution of trade tariffs, both globally and between the U.S. and China specifically, carries the risk of negatively impacting overall economic conditions, which could have negative repercussions on the Company. More directly, imposition of tariffs has caused and could cause further increases in the costs of our raw materials which we may not be able to pass on to our customers in part or in full, which would directly and negatively impact our business. We purchase a significant amount of raw material components, including products manufactured in our China facilities, which are subject to the recently-enacted tariffs. We estimate an increase in raw material costs ranging from $3 to $5 million on an annualized basis starting in the 2018 fourth quarter, and we may not be able to mitigate the impact from these tariffs or additional future tariffs.

There were no other material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017. You should carefully consider the risks and uncertainties described therein.

ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities During Third Quarter 2018

Period |  |  | (a) Total Number of Shares Purchased (1) |  |  | (b) Average Price Paid per Share |  |  | (c) Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs |  |  | (d) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (2) |
July 1, 2018 to July 31, 2018 |  |  |  |  | 121,615 |  |  |  | $ | 41.59 |  |  |  |  | 121,615 |  |  |  | $ | 266,176,633
August 1, 2018 to August 31, 2018 |  |  |  |  | 211,527 |  |  |  | $ | 47.28 |  |  |  |  | 211,527 |  |  |  | $ | 256,175,183
September 1, 2018 to September 30, 2018 |  |  |  |  | 604,782 |  |  |  | $ | 47.71 |  |  |  |  | 604,782 |  |  |  | $ | 227,322,571

| (1) | All shares were purchased on the open-market in accordance with Gentherm’s Stock Repurchase Program, including, in part, pursuant to a plan adopted by the Company in accordance with Rule 10b5-1 promulgated by the U.S. Securities and Exchange Commission.

| (2) | The Stock Repurchase Program was originally approved by the Company’s Board of Directors and announced on December 16, 2016. As amended on June 25, 2018, the Stock Repurchase Program authorized Gentherm to repurchase shares up to $300 million. The Stock Repurchase Program expires on December 16, 2020. The authorization of this Stock Repurchase Program does not require that the Company repurchase any specific dollar value or number of share and may be modified, extended or terminated by the Company’s Board of Directors at any time.

40

ITEM 6. | EXHIBI TS

Exhibits to this Report are as follows:

|  |  |  |  |  | Incorporated by Reference
Exhibit Number |  | Exhibit Description |  | Filed Herewith |  | Form |  | Period Ending |  | Exhibit / Appendix Number |  | Filing Date
31.1 |  | Section 302 Certification – CEO |  | X |  |  |  |  |  |  |  |
31.2 |  | Section 302 Certification – CFO |  | X |  |  |  |  |  |  |  |
32.1** |  | Section 906 Certification – CEO |  | X |  |  |  |  |  |  |  |
32.2** |  | Section 906 Certification – CFO |  | X |  |  |  |  |  |  |  |
101.INS |  | XBRL Instance Document. |  | X |  |  |  |  |  |  |  |
101.SCH |  | XBRL Taxonomy Extension Schema Document. |  | X |  |  |  |  |  |  |  |
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document. |  | X |  |  |  |  |  |  |  |
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document. |  | X |  |  |  |  |  |  |  |
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document. |  | X |  |  |  |  |  |  |  |
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document. |  | X |  |  |  |  |  |  |  |

* Indicates management contract or compensatory plan or arrangement

** Documents are furnished not filed

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Gentherm Incorporated
/s/ PHILLIP EYLER
Phillip Eyler
Chief Executive Officer
(Duly Authorized Officer)
Date: November 1, 2018

/s/ BARRY G. STEELE
Barry G. Steele
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
Date: November 1, 2018

42